Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3017315	u-amyl	u/l (u/l)	2093	2586	0.04%
3017315	u-amyl	— (—)	166	178	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Acute pancreatitis

313

284

11.37

296.86

1.6

1.1

965.09

203.86

u/l

4.08

269

268

Abdominal and pelvic pain

726

654

5.62

282.54

1.3

1.1

328.64

386.23

u/l

0.31

669

612

Acute pancreatitis (for exclusion)

313

334

9.66

264.64

1.6

1.2

965.09

228.51

u/l

3.83

269

311

Disorders of gallbladder, biliary tract and pancreas

810

1209

4.27

261.40

1.4

1.1

499.26

206.10

u/l

4.18

732

1151

Symptoms and signs involving the digestive system and abdomen

682

654

5.27

249.50

1.3

1.1

338.08

386.23

u/l

0.24

628

612

Chronic pancreatitis

189

168

11.63

181.88

1.9

1.1

536.13

208.55

u/l

1.86

162

159

GASTRO-related operations

467

470

5.01

163.37

1.3

1.1

361.12

218.18

u/l

1.75

432

443

Any gastric operation

467

470

5.01

163.37

1.3

1.1

361.12

218.18

u/l

1.75

432

443

Cholelithiasis, broad definition with cholecystitis

551

1124

3.32

130.20

1.3

1.1

240.24

202.73

u/l

0.77

507

1070

Cholelithiasis

527

1109

3.30

124.17

1.3

1.1

237.82

202.16

u/l

0.70

484

1055

Other diseases of intestines

639

1218

3.00

121.57

1.3

1.2

286.02

363.94

u/l

0.65

599

1134

Low back pain

476

1051

3.27

112.37

1.4

1.2

226.46

385.66

u/l

2.23

455

981

Diseases of oesophagus, stomach and duodenum

652

1415

2.77

109.94

1.4

1.2

257.01

327.86

u/l

1.02

598

1337

Pain (limb, back, neck, head abdominally)

368

444

4.17

105.80

1.3

1.1

393.13

347.62

u/l

0.18

341

407

Substance abuse, excluding more controls

376

934

3.46

101.69

1.4

1.2

303.97

340.22

u/l

0.26

346

868

393

1092

3.28

99.29

1.4

1.2

432.58

306.91

u/l

0.97

355

1022

405

1126

3.19

97.35

1.4

1.2

463.59

299.37

u/l

1.41

367

1055

Alcohol use disorder, Swedish definition

376

1055

3.29

96.11

1.4

1.2

471.83

307.58

u/l

1.27

340

987

Lower back pain or/and sciatica

621

1583

2.58

93.69

1.4

1.2

237.81

340.43

u/l

1.69

594

1467

Hernia of abdominal wall, postoperative

124

160

7.84

89.93

1.5

1.1

274.09

214.65

u/l

0.77

116

147

Dorsalgia

550

1081

2.74

87.85

1.4

1.2

265.73

387.89

u/l

1.40

521

1008

Cholecystectomy

448

1371

2.84

87.44

1.4

1.2

325.37

310.44

u/l

0.09

413

1279

Tramadol

462

974

2.93

86.92

1.4

1.2

279.91

370.83

u/l

0.76

434

906

Diverticular disease of intestine

420

876

3.08

86.91

1.3

1.2

276.86

397.02

u/l

0.72

392

812

Substance abuse

376

1158

3.07

86.35

1.4

1.2

303.97

340.52

u/l

0.30

346

1080

Gastrointestinal diseases

280

319

4.42

86.10

1.3

1.1

358.33

214.39

u/l

1.98

259

303

Sciatica+with lumbago

318

866

3.40

85.84

1.3

1.2

231.06

407.13

u/l

1.78

304

803

Nausea and vomiting

155

259

5.91

85.80

1.4

1.2

304.04

267.13

u/l

0.18

143

236

Mental and behavioural disorders due to psychoactive substance use

382

1193

2.99

83.29

1.4

1.2

299.94

336.61

u/l

0.32

351

1115

Headache

392

1054

2.99

82.40

1.4

1.2

260.39

368.08

u/l

1.10

368

988

Other functional intestinal disorders

281

737

3.56

81.63

1.5

1.2

192.25

359.96

u/l

2.35

256

680

Pain in throat and chest

480

1046

2.77

81.27

1.4

1.2

235.98

368.12

u/l

1.97

443

986

Irritable bowel syndrome

194

429

4.57

80.69

1.5

1.1

234.05

328.06

u/l

1.20

183

391

Oxycodone

252

607

3.79

79.36

1.5

1.2

225.61

405.96

u/l

1.49

245

563

Other dorsopathies, not elsewhere classified

541

1084

2.62

79.31

1.4

1.2

261.49

387.77

u/l

1.47

504

1010

General symptoms and signs

578

1143

2.55

78.75

1.4

1.2

279.92

359.71

u/l

0.82

537

1073

Parasetamol

376

612

3.13

73.75

1.3

1.2

409.60

335.48

u/l

0.35

349

567

Pain in joint

255

425

3.84

73.30

1.4

1.1

240.09

355.98

u/l

0.74

243

389

Abnormalities of breathing

480

1071

2.62

72.39

1.2

281.71

366.52

u/l

0.54

442

1010

Mental and behavioural disorders due to alcohol

317

1026

2.99

69.97

1.4

1.2

329.71

351.58

u/l

0.14

289

956

Other soft tissue disorders, not elsewhere classified

496

1175

2.49

67.82

1.3

1.2

282.76

298.74

u/l

0.11

460

1103

Alcohol use disorder, ICD-based

268

862

3.14

64.76

1.5

1.2

349.16

375.02

u/l

0.14

244

801

Mental and behavioural disorders due to alcohol, excluding acute intoxication

285

947

3.02

64.47

1.5

1.2

336.56

363.92

u/l

0.17

260

883

Other intervertebral disc disorders

427

996

2.59

64.11

1.3

1.2

286.94

393.13

u/l

0.91

397

929

Codeine

473

1045

2.47

62.49

1.4

1.2

308.40

358.76

u/l

0.36

443

973

Fever of other and unknown origin

300

946

2.84

59.38

1.3

1.2

282.71

351.03

u/l

0.50

288

883

Spondylopathies

393

909

2.60

59.02

1.4

1.2

198.72

406.23

u/l

3.08

367

845

Gastro-oesophageal reflux disease

369

1254

2.55

58.97

1.2

278.20

336.04

u/l

0.30

335

1182

Functional dyspepsia

176

459

3.87

58.95

1.4

1.2

184.23

293.88

u/l

2.34

164

426

Pain in limb

420

1151

2.45

58.08

1.2

251.43

294.27

u/l

0.33

389

1081

Pain, not elsewhere classified

178

480

3.74

56.82

1.5

1.2

198.90

439.72

u/l

1.81

167

442

Dorsopathies

496

1089

2.32

56.51

1.3

1.2

249.93

386.41

u/l

1.74

460

1015

Other diseases of biliary tract

108

7.55

55.98

1.3

1.2

244.42

193.60

u/l

0.24

103

Alcohol dependence

187

532

3.55

55.19

1.6

1.2

327.97

472.91

u/l

0.77

167

492

Other headache syndromes

250

861

2.92

53.55

1.4

1.2

234.65

325.39

u/l

0.90

231

800

Dyspnoea

470

1573

2.22

53.16

1.2

190.11

347.91

u/l

4.36

433

1474

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

166

450

3.70

52.24

1.3

298.83

327.03

u/l

0.13

154

416

Pain in thoracic spine

109

219

5.04

51.07

1.3

1.2

182.62

440.24

u/l

1.71

103

203

Alcohol abuse, main dg, excluding more controls

117

252

4.70

50.51

1.6

1.2

262.88

422.82

u/l

0.95

105

234

Opioids

462

1060

2.27

50.50

1.4

1.2

275.61

362.94

u/l

0.83

436

987

Mood disorders, excluding more controls

458

1229

2.23

50.05

1.3

1.2

279.36

341.91

u/l

0.58

425

1145

Anaemias

133

185

4.73

49.70

1.7

1.1

227.57

376.68

u/l

0.51

120

177

Shoulder lesions

391

999

2.38

49.58

1.3

1.2

278.13

298.19

u/l

0.15

369

934

Dysphagia

116

252

4.64

49.47

1.2

1.1

154.80

411.91

u/l

1.30

105

229

Concussion

261

765

2.80

49.41

1.3

1.2

310.64

328.07

u/l

0.09

246

727

Constipation

456

1451

2.18

49.05

1.3

1.2

274.56

328.01

u/l

0.30

415

1358

Lumbar disc prolapse

313

943

2.56

49.03

1.3

1.2

289.95

403.51

u/l

0.89

291

879

Anxiety disorders, excluding more controls

407

1154

2.30

48.90

1.3

1.2

258.18

344.45

u/l

0.88

378

1074

Any mental disorder

524

1247

2.11

47.63

1.4

1.2

276.92

338.93

u/l

0.62

483

1163

Intracranial trauma

290

775

2.64

47.43

1.3

1.2

305.04

326.46

u/l

0.12

273

737

Codeine or tramadol medication

556

1501

2.03

47.05

1.3

1.2

297.12

325.38

u/l

0.24

522

1403

Asthma, excluding more controls

367

792

2.43

46.37

1.4

1.2

233.12

391.57

u/l

1.72

345

742

Infections, IBD-co-morbidities

120

5.76

45.76

1.2

176.81

272.36

u/l

1.57

114

Paralytic ileus and intestinal obstruction

148

410

3.64

45.47

1.3

1.2

293.86

470.22

u/l

0.93

140

372

Symptoms and signs involving the circulatory and respiratory systems

464

1073

2.17

45.36

1.3

1.2

270.94

366.03

u/l

1.09

421

1012

Diarrhoea and gastroenteritis of presumed infectious origin

498

1605

2.05

45.29

1.3

1.2

247.67

332.23

u/l

1.28

457

1505

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

142

160

4.47

44.57

1.3

1.1

370.32

399.87

u/l

0.07

130

149

Asthma (only as main-diagnosis), excluding more controls

337

792

2.44

44.45

1.3

1.2

224.57

391.57

u/l

1.88

320

742

Intestinal infectious diseases

552

1592

1.99

44.42

1.3

1.2

236.24

336.18

u/l

1.76

509

1493

Other antidepressants

498

1230

2.08

44.01

1.3

1.2

287.91

344.58

u/l

0.53

458

1155

Asthma

378

856

2.32

43.69

1.4

1.2

235.84

375.55

u/l

1.58

355

802

Psychiatric diseases

458

1076

2.14

43.08

1.3

1.2

311.10

350.39

u/l

0.27

418

1005

Spondylosis

261

822

2.60

43.01

1.3

1.2

182.23

413.99

u/l

3.24

242

766

Asthma (mode)

373

867

2.31

42.93

1.3

1.2

234.50

373.16

u/l

1.59

352

813

Depression or dysthymia

331

756

2.43

42.63

1.4

1.2

300.21

383.67

u/l

0.54

309

707

Asthma (only as main-diagnosis)

347

856

2.36

42.55

1.3

1.2

221.82

375.55

u/l

1.84

330

802

Substance use, excluding alcohol

135

369

3.70

42.43

1.5

1.2

211.83

409.39

u/l

1.83

125

341

Benzodiazepine use

491

1691

2.01

42.43

1.3

1.2

251.14

330.51

u/l

1.09

456

1583

Diarrhoea and gastroenteritis of presumed infectious origin

361

1479

2.21

42.31

1.3

1.2

241.16

328.58

u/l

1.23

329

1383

Other disorders of fluid, electrolyte and acid-base balance

188

602

3.00

41.81

1.3

1.2

284.00

374.54

u/l

0.47

170

563

Intestinal infectious diseases

458

1733

2.01

40.80

1.3

1.2

252.79

331.25

u/l

1.13

422

1625

Diseases of the digestive system

253

1009

2.51

40.46

1.4

1.2

249.82

347.54

u/l

1.02

232

934

Oral corticosteroids

510

1544

1.97

40.30

1.4

1.2

298.33

323.09

u/l

0.14

484

1440

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

120

314

3.86

40.21

1.4

1.3

255.32

313.17

u/l

0.37

110

292

Alcohol abuse, main dg

117

303

3.91

39.80

1.6

1.2

262.88

462.64

u/l

1.43

105

278

Malaise and fatigue

245

772

2.57

39.25

1.2

173.97

361.95

u/l

2.53

229

716

Rotator cuff syndrome

304

933

2.35

39.22

1.3

1.2

284.88

303.09

u/l

0.12

285

878

Myalgia

136

395

3.47

39.02

1.2

229.16

322.89

u/l

1.03

127

365

Poisoning by medicine

143

434

3.33

38.32

1.4

1.3

312.99

354.50

u/l

0.19

133

401

Inflammatory bowel disease treatment related agents

534

1572

1.91

38.07

1.4

1.2

289.56

321.67

u/l

0.20

503

1465

525

1410

1.93

38.01

1.3

1.2

268.96

346.33

u/l

0.86

490

1315

Other/unspecified dorsalgia

180

627

2.86

37.35

1.3

1.2

252.44

427.28

u/l

1.19

175

575

Acute alcohol intoxication, ICD10

135

402

3.39

37.31

1.5

1.2

287.58

477.89

u/l

1.08

121

372

Mood [affective] disorders

486

1637

1.93

37.26

1.3

1.2

273.76

328.82

u/l

0.62

453

1530

408

1199

2.07

37.18

1.3

1.2

271.81

344.66

u/l

0.67

375

1127

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

408

1199

2.07

37.18

1.3

1.2

271.81

344.66

u/l

0.67

375

1127

Other bacterial diseases

478

1566

1.94

37.17

1.3

1.2

227.39

338.30

u/l

1.96

436

1471

Mood disorders

486

1638

1.93

37.01

1.3

1.2

273.76

328.76

u/l

0.62

453

1531

Symptoms and signs involving cognition, perception, emotional state and behaviour

460

1612

1.95

36.83

1.3

1.2

243.43

330.93

u/l

1.25

423

1518

All kidney diseases

463

1645

1.93

35.92

1.3

1.2

213.12

339.01

u/l

2.80

433

1535

Injuries to the head

515

1693

1.88

35.85

1.3

1.2

276.63

322.37

u/l

0.50

486

1579

Excessive earwax

279

1203

2.28

35.77

1.3

1.2

317.36

327.92

u/l

0.05

264

1106

Depression

454

1590

1.94

35.77

1.3

1.2

264.06

331.27

u/l

0.84

422

1487

Soft tissue disorders

454

1180

1.99

35.71

1.4

1.2

292.47

298.58

u/l

0.04

416

1108

Suicide or other Intentional self-harm

153

506

3.05

35.55

1.4

1.3

303.31

352.40

u/l

0.24

142

463

First line medication for Crohn's disease

508

1458

1.89

35.01

1.3

1.2

319.82

317.72

u/l

0.01

475

1362

Anxiety disorders

428

1528

1.96

34.82

1.3

1.2

256.75

334.21

u/l

0.99

399

1433

ILD medications: prednisolone, methylprednisolone, prednisone

502

1494

1.89

34.71

1.4

1.2

292.76

324.68

u/l

0.18

471

1394

Implicit Sepsis

362

1328

2.06

34.60

1.2

275.47

343.89

u/l

0.63

331

1241

Influenza and pneumonia

486

1647

1.88

34.46

1.2

263.33

327.00

u/l

0.76

445

1548

Poisoning by drugs, medicaments and biological substances

148

489

3.05

34.46

1.4

1.3

329.37

352.88

u/l

0.10

138

451

ILD medications

518

1511

1.86

34.36

1.4

1.2

290.13

322.80

u/l

0.20

486

1410

Anxiety (asthma-related co-morbidities)

283

970

2.27

34.35

1.3

1.2

271.02

323.33

u/l

0.43

258

909

Neurotic, stress-related and somatoform disorders

423

1520

1.95

34.21

1.3

1.2

258.47

335.37

u/l

0.97

394

1426

Acute upper respiratory infections

475

1550

1.89

34.08

1.3

1.2

275.31

332.75

u/l

0.57

445

1443

Cervical disc disorders

174

634

2.76

33.86

1.2

193.23

425.80

u/l

2.60

165

586

Complications of surgical and medical care, not elsewhere classified

461

1679

1.89

33.49

1.3

1.2

309.97

311.87

u/l

0.01

428

1570

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

166

594

2.81

33.47

1.3

298.83

332.78

u/l

0.17

154

547

Asthma-related infections

289

1305

2.18

33.43

1.3

1.2

203.34

343.43

u/l

2.82

270

1209

Asthma, hospital admission 2, infections

289

1305

2.18

33.43

1.3

1.2

203.34

343.43

u/l

2.82

270

1209

Acute alcohol intoxication

151

514

2.96

33.37

1.5

1.2

280.46

481.45

u/l

1.35

137

475

Other or unspecified ileus, impaction or obstruction

101

268

3.80

33.20

1.4

1.2

234.91

465.68

u/l

1.28

243

Dizziness and giddiness

356

1394

2.03

33.01

1.3

1.2

253.53

334.48

u/l

0.85

327

1305

Other bacterial diseases

440

1570

1.89

32.05

1.2

241.59

336.16

u/l

1.38

399

1472

Migraine

239

829

2.35

31.86

1.3

1.2

277.11

301.60

u/l

0.18

230

773

COPD/asthma/ILD related infections

456

1200

1.91

31.84

1.2

286.99

344.57

u/l

0.48

416

1128

COPD/asthma related infections

456

1200

1.91

31.84

1.2

286.99

344.57

u/l

0.48

416

1128

Symptoms and signs concerning food and fluid intake

126

5.21

31.77

1.4

1.1

239.75

305.86

u/l

0.39

118

226

955

2.36

31.73

1.3

1.2

207.22

318.19

u/l

2.17

211

876

Complications of procedures, not elsewhere classified

381

1632

1.94

31.24

1.2

314.59

313.44

u/l

0.01

355

1524

Neurological diseases, wide definition

133

193

3.47

30.76

1.3

1.1

387.91

292.83

u/l

0.43

119

184

Cough

191

721

2.52

30.67

1.2

223.14

394.34

u/l

1.56

174

678

Hypo-osmolality and hyponatraemia

110

326

3.39

30.42

1.3

1.2

201.45

311.88

u/l

1.21

306

Examination and observation for other reasons

305

839

2.11

29.17

1.3

1.2

207.43

390.14

u/l

2.61

280

793

Gastroduodenal ulcer

131

444

2.96

29.06

1.3

1.2

264.37

404.66

u/l

0.68

117

415

Nerve, nerve root and plexus disorders

476

1629

1.79

28.96

1.2

268.55

310.66

u/l

0.49

437

1531

Implicit Sepsis

371

1423

1.91

28.56

1.2

1.3

266.76

337.36

u/l

0.74

340

1333

Pneumonias (Asthma/COPD co-morbidities)

450

1677

1.81

28.54

1.2

281.09

323.18

u/l

0.40

414

1573

Non-selective monoamine reuptake inhibitors

190

757

2.43

28.44

1.4

1.2

218.01

387.53

u/l

1.69

169

706

Recurrent or chronic depression

187

522

2.53

28.34

1.4

1.2

335.37

385.50

u/l

0.20

176

486

Spinal stenosis

216

703

2.34

28.31

1.4

1.2

180.15

433.59

u/l

2.86

201

653

Episodal and paroxysmal disorders

470

1323

1.81

28.27

1.2

335.90

324.51

u/l

0.05

434

1242

Asthma, unspecified (mode), excluding more controls

226

739

2.30

28.24

1.4

1.2

213.40

396.57

u/l

1.94

208

691

Hernia

420

1536

1.84

28.17

1.3

1.2

413.12

298.90

u/l

0.53

380

1438

Other gastritis (incl. Duodenitis)

116

375

3.12

28.13

1.5

1.2

377.26

396.28

u/l

0.05

109

351

All pneumoniae

451

1682

1.80

28.10

1.2

281.38

323.02

u/l

0.39

414

1579

Intestinal stricture

163

633

2.59

28.09

1.3

1.2

294.97

439.53

u/l

0.85

155

582

Implicit bacterial Sepsis

217

819

2.30

28.02

1.2

264.10

367.29

u/l

0.70

194

761

Cystitis

376

1169

1.92

27.95

1.4

1.2

209.11

345.92

u/l

2.36

357

1092

Cervicocranial syndrome

146

4.57

27.73

1.2

214.74

356.95

u/l

1.06

134

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

439

1670

1.80

27.52

1.2

280.05

323.66

u/l

0.41

405

1564

Renal tubulo-interstitial diseases

392

1582

1.85

27.47

1.2

213.14

332.63

u/l

2.30

365

1472

Asthma, including avohilmo

517

1682

1.73

27.32

1.3

1.2

223.20

343.11

u/l

2.70

488

1567

Bronchitis

472

1690

1.76

27.31

1.3

1.2

247.58

331.96

u/l

1.14

435

1585

Neurological diseases

360

927

1.96

27.15

1.2

302.81

332.67

u/l

0.22

326

881

Certain infectious and parasitic diseases

420

1138

1.85

27.00

1.3

1.2

383.84

304.52

u/l

0.36

377

1069

Cervicalgia

100

303

3.32

27.00

1.4

1.2

251.62

402.22

u/l

0.97

276

Personality disorders, excluding more controls

122

419

2.93

26.61

1.3

270.89

345.39

u/l

0.37

111

385

All anxiety disorders

285

1112

2.03

26.59

1.4

1.2

269.88

332.31

u/l

0.58

260

1041

Implicit bacterial Sepsis

198

760

2.32

26.29

1.2

272.72

377.26

u/l

0.63

176

706

Assault

232

3.66

26.19

1.4

1.3

404.12

360.44

u/l

0.13

212

Acute upper respiratory infections of multiple and unspecified sites

334

1294

1.92

26.15

1.3

1.2

280.32

331.99

u/l

0.39

311

1203

Asthma, unspecified (mode)

231

796

2.19

25.98

1.4

1.2

212.83

379.22

u/l

1.85

212

744

Behavioural syndromes associated with physiological disturbances and physical factors

409

1619

1.80

25.84

1.4

1.2

260.02

332.16

u/l

0.90

380

1518

Acute gastritis

5.33

25.59

1.3

1.2

347.62

260.71

u/l

0.17

Acute sinusitis

238

1047

2.11

25.40

1.2

1.3

267.05

340.39

u/l

0.60

222

973

Pneumonia, organism unspecified

396

1542

1.81

25.37

1.3

273.69

333.22

u/l

0.56

366

1445

Chronic lower respiratory diseases

519

1633

1.70

25.29

1.3

1.2

236.71

345.36

u/l

2.20

486

1524

Other specific joint derangements/joint disorders

324

1086

1.93

25.22

1.4

1.2

228.99

367.53

u/l

1.92

304

1013

Depression medications

126

203

3.13

25.17

1.3

1.1

459.50

367.62

u/l

0.23

115

195

Condition for Implicit Sepsis (Organ dysfunction codes)

393

1506

1.80

25.06

1.2

251.78

330.94

u/l

1.00

362

1413

Other diseases of the digestive system

161

658

2.46

24.98

1.5

1.2

251.36

421.29

u/l

1.29

149

613

Cardiac arrhythmias

259

810

2.08

24.81

1.2

268.71

427.23

u/l

1.34

238

770

Percutaneous Coronary Intervention

343

1117

1.89

24.60

1.3

1.2

235.80

373.11

u/l

1.78

313

1043

Condition for Implicit Sepsis (Organ dysfunction codes)

374

1456

1.82

24.58

1.2

1.3

268.83

332.96

u/l

0.65

343

1366

Coronary revascularization (ANGIO or CABG)

343

1117

1.89

24.50

1.3

1.2

234.68

373.11

u/l

1.81

313

1043

Other nutritional deficiencies

299

1473

1.92

24.47

1.4

1.2

291.19

319.41

u/l

0.21

280

1374

Falls/tendency to fall

469

1356

1.74

24.46

1.4

1.2

275.35

341.22

u/l

0.68

436

1266

Candidiasis

147

583

2.54

24.34

1.4

1.2

214.46

286.25

u/l

1.09

136

540

GI-bleeding

160

660

2.44

24.34

1.3

1.2

256.65

420.37

u/l

1.21

148

615

Other reaction to severe stress, and adjustment disorders

173

739

2.35

24.34

1.3

294.10

301.66

u/l

0.04

161

687

Migraine with aura

121

435

2.80

24.32

1.3

353.44

257.92

u/l

0.51

114

408

Asthma (diagnoses ohter than nonallergic)

382

1785

1.78

24.16

1.4

1.2

217.16

335.64

u/l

2.83

357

1669

Other septicaemia

180

753

2.31

24.10

1.3

1.2

189.23

397.20

u/l

2.66

163

700

Asthma, hospital admissions , main diagnosis only

361

1773

1.80

24.00

1.3

1.2

220.58

331.63

u/l

2.31

342

1651

Insomnia

381

1557

1.79

23.87

1.4

1.2

265.67

331.97

u/l

0.74

352

1461

Bacterial Sepsis

213

847

2.16

23.68

1.2

280.54

365.90

u/l

0.53

190

786

Metabolic disorders

412

1431

1.76

23.68

1.3

1.2

269.59

322.51

u/l

0.59

372

1347

Emergency coronary revascularization (for ACS)

364

1213

1.83

23.67

1.3

1.2

233.24

370.43

u/l

1.98

331

1131

Sleep disorders

387

1580

1.77

23.63

1.4

1.2

262.24

332.20

u/l

0.82

359

1480

Injuries to the thorax

215

1020

2.12

23.41

1.2

217.24

369.75

u/l

2.30

202

940

Osteopathies and chondropathies

260

1227

1.98

23.38

1.3

204.19

346.43

u/l

2.60

247

1127

Intracranial injury

256

1222

1.99

23.33

1.3

1.2

279.38

337.97

u/l

0.45

242

1129

Gastric ulcer

266

3.29

23.22

1.4

1.1

297.00

300.81

u/l

0.01

249

Hypertensive diseases (excluding secondary)

221

591

2.18

23.06

1.4

1.2

217.02

457.53

u/l

2.05

200

564

Sequelae of external causes of morbidity and mortality

133

517

2.59

22.99

1.3

1.2

293.14

308.96

u/l

0.07

127

475

Haemorrhoids and perianal venous thrombosis

136

533

2.56

22.97

1.1

1.2

197.98

412.12

u/l

2.45

129

488

Type 2 diabetes, wide definition

316

1074

1.89

22.96

1.2

1.1

154.61

235.21

u/l

4.61

299

1013

Convulsions, not elsewhere classified

108

372

2.88

22.92

1.4

1.2

261.23

430.60

u/l

0.75

343

Bleeding

362

1441

1.79

22.78

1.2

224.83

357.14

u/l

2.35

337

1335

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

270

3.25

22.71

1.7

1.2

314.16

389.55

u/l

0.33

247

Alcoholic liver disease

176

3.85

22.54

1.9

1.3

359.19

437.12

u/l

0.24

164

Explicit Sepsis

201

877

2.15

22.52

1.3

1.2

192.70

364.18

u/l

2.47

182

814

Selective serotonin reuptake inhibitors

412

1234

1.75

22.26

1.2

346.34

344.54

u/l

0.01

383

1158

Deforming dorsopathies

120

451

2.67

22.19

1.2

231.58

447.02

u/l

1.58

112

412

Noninfective enteritis and colitis

219

1067

2.06

22.19

1.3

289.19

361.14

u/l

0.50

202

984

Sleep disorders (combined)

475

1492

1.67

22.10

1.3

1.2

331.75

321.07

u/l

0.05

433

1402

Obesity and other hyperalimentation

281

1440

1.89

22.03

1.4

1.2

277.18

324.75

u/l

0.40

265

1341

Syncope and collapse

184

712

2.22

22.02

1.2

410.31

374.69

u/l

0.13

167

657

Diseases of liver

171

760

2.26

22.00

1.5

1.2

502.95

353.42

u/l

0.35

157

709

Schizophrenia or delusion, excluding more controls

131

511

2.55

21.97

1.3

1.2

255.39

375.41

u/l

0.65

122

470

Obesity

280

1437

1.89

21.95

1.4

1.2

276.84

324.12

u/l

0.40

264

1338

Septicaemia

193

839

2.16

21.95

1.3

1.2

189.84

389.63

u/l

2.92

175

778

Ischemic heart diseases

348

1160

1.81

21.74

1.3

1.2

272.59

366.12

u/l

0.94

314

1084

Other symptoms and signs involving the digestive system and abdomen

145

4.09

21.70

1.2

1.1

227.69

226.71

u/l

0.01

134

Major coronary heart disease event

353

1191

1.79

21.57

1.3

1.2

249.77

368.62

u/l

1.49

324

1108

Type 2 diabetes

420

1442

1.71

21.45

1.3

1.2

201.83

362.65

u/l

3.71

384

1350

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

417

1703

1.69

21.44

1.4

1.2

290.23

320.11

u/l

0.28

383

1595

Asthma-related pneumonia

168

752

2.24

21.15

1.3

1.2

172.83

391.92

u/l

2.88

160

688

Asthma-related pneumonia or sepsis

168

753

2.24

21.08

1.3

1.2

172.83

391.39

u/l

2.88

160

689

Asthma, hospital admissions 3, pneumonia

168

753

2.24

21.08

1.3

1.2

172.83

391.39

u/l

2.88

160

689

Other diseases of urinary system

415

1371

1.71

21.01

1.4

1.2

272.51

332.59

u/l

0.39

385

1276

Soft tissue disorders related to use, overuse and pressure

128

511

2.52

20.98

1.5

1.1

422.51

355.64

u/l

0.12

115

473

Diabetes mellitus

431

1508

1.67

20.61

1.3

1.2

202.52

357.88

u/l

3.75

394

1411

Excluding asthma or asthma-COPD overlap

319

866

1.85

20.58

1.3

1.2

332.94

379.47

u/l

0.20

287

812

Implicit viral Sepsis

141

594

2.39

20.56

1.3

1.2

247.86

390.70

u/l

0.77

129

551

Other disorders of lacrimal gland

164

738

2.23

20.52

1.3

1.2

208.24

303.01

u/l

1.90

154

680

Diabetes, varying definitions

429

1506

1.67

20.50

1.3

1.2

202.98

358.24

u/l

3.73

392

1409

Other pulmonary diagnosis

318

866

1.84

20.33

1.3

1.2

345.14

379.47

u/l

0.14

285

812

COPD differential diagnosis

318

867

1.84

20.26

1.3

1.2

333.98

373.16

u/l

0.17

286

813

ILD differential diagnosis

318

867

1.84

20.25

1.3

1.2

333.98

373.16

u/l

0.17

286

813

Other disorders of urethra and urinary system

285

1113

1.85

20.15

1.3

1.2

299.03

323.88

u/l

0.10

264

1041

Implicit viral Sepsis

101

366

2.78

20.11

1.3

156.87

339.85

u/l

3.40

340

Polyarthropathies

286

1006

1.86

20.10

1.3

1.2

230.63

365.93

u/l

1.72

267

934

Use of hypnotics and sedatives

449

1569

1.65

20.08

1.3

1.2

270.02

334.64

u/l

0.77

410

1476

Viral Sepsis

101

367

2.77

20.01

1.3

156.87

339.74

u/l

3.41

341

Cardiovascular diseases

235

626

2.02

19.98

1.3

1.2

299.80

396.59

u/l

0.62

216

599

Hernia of abdominal wall

210

1050

2.01

19.97

1.5

1.2

517.92

316.84

u/l

0.62

191

973

Diseases of the musculoskeletal system and connective tissue

208

491

2.13

19.80

1.3

1.2

290.26

368.90

u/l

0.44

192

463

Cardiovascular diseases (excluding rheumatic etc)

252

745

1.95

19.72

1.3

1.2

294.10

412.48

u/l

0.82

230

712

Certain infectious and parasitic diseases

295

792

1.87

19.71

1.3

1.2

297.27

294.10

u/l

0.02

266

746

Fentanyl

147

3.90

19.64

1.3

1.1

183.67

333.95

u/l

1.60

136

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

189

557

2.15

19.58

1.3

1.2

217.32

461.87

u/l

1.96

177

531

Ovarian cyst

161

401

2.33

19.55

1.2

1.3

302.04

243.30

u/l

0.37

152

373

Bacterial infection, other or unspecified

245

1089

1.91

19.53

1.2

230.51

341.68

u/l

1.59

227

1016

Fall on same level

477

1617

1.61

19.51

1.3

1.2

320.09

317.25

u/l

0.02

452

1504

Other anxiety disorders

197

835

2.05

19.39

1.4

1.3

248.59

317.82

u/l

0.55

177

773

Antihypertensive medication - note that there are other indications

232

614

2.01

19.29

1.3

1.2

361.83

411.10

u/l

0.22

215

582

Migraine with aura and triptan purchases

272

3.04

19.19

1.3

1.4

346.92

259.94

u/l

0.30

250

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

395

1423

1.68

19.14

1.3

1.2

195.12

364.77

u/l

4.02

363

1330

Oedema, not elsewhere classified

133

556

2.37

19.12

1.6

1.2

185.42

413.31

u/l

2.09

122

516

Diabetes, insulin treatment (Kela reimbursement)

418

1538

1.65

18.89

1.3

1.2

191.86

354.45

u/l

4.24

385

1437

Other heart diseases, wide

383

1397

1.68

18.79

1.3

1.2

262.91

347.11

u/l

1.01

349

1315

Acute tubulo-interstitial nephritis

265

1252

1.83

18.70

1.2

210.87

332.80

u/l

1.95

252

1164

Dental pulpitis, including avohilmo

381

1480

1.67

18.70

1.3

1.2

288.74

338.60

u/l

0.50

361

1378

Diseases of the skin and subcutaneous tissue

414

1253

1.66

18.60

1.2

228.05

358.16

u/l

2.14

361

1190

Diseases of appendix

317

1659

1.73

18.47

1.3

1.2

234.54

338.53

u/l

1.76

297

1548

Bacterial infection, other or unspecified

224

1014

1.92

18.40

1.2

206.26

351.47

u/l

2.35

207

948

Allergic asthma (mode), excluding more controls

104

392

2.61

18.32

1.4

1.3

240.58

311.09

u/l

0.79

368

Diabetes medication

429

1572

1.62

18.27

1.3

1.2

203.61

349.76

u/l

3.58

394

1472

General examination and investigation of persons without complaint and reported diagnosis

293

843

1.82

18.20

1.3

1.2

269.76

389.58

u/l

1.02

273

797

Diaphragmatic hernia

154

714

2.17

17.96

1.2

390.59

310.26

u/l

0.18

138

663

Superficial injury of head

113

459

2.47

17.92

1.6

1.2

284.97

328.71

u/l

0.17

103

418

Asthma/COPD (KELA code 203)

389

1632

1.64

17.76

1.3

1.2

206.54

345.47

u/l

3.43

367

1523

Other bacterial intestinal infections

324

2.77

17.64

1.2

204.67

332.45

u/l

1.47

305

Appendicitis, broad definition

312

1654

1.71

17.62

1.3

1.2

236.29

338.89

u/l

1.71

293

1543

Heart failure, not strict

305

1189

1.75

17.61

1.3

1.2

253.21

360.77

u/l

1.04

284

1099

Type 2 diabetes, definitions combined

390

1395

1.65

17.55

1.3

1.2

204.02

364.29

u/l

3.54

361

1305

Allergic asthma (mode)

104

401

2.55

17.52

1.4

1.3

240.58

309.31

u/l

0.78

377

Type 2 diabetes, definitions combined, including avohilmo

390

1384

1.64

17.51

1.3

1.2

205.24

360.38

u/l

3.33

363

1296

Alcohol withdrawal state with delirium

124

4.00

17.45

1.5

1.3

282.62

426.17

u/l

0.64

117

Hypermobility syndrome

4.66

17.29

1.4

1.2

208.70

333.81

u/l

0.47

Other noninfective gastroenteritis and colitis

118

497

2.39

17.29

1.2

1.3

334.03

291.68

u/l

0.17

111

457

Type 2 diabetes, strict (exclude DM1)

391

1406

1.64

17.26

1.3

1.2

203.70

362.70

u/l

3.53

362

1316

Dermatitis and eczema

449

1769

1.58

17.21

1.2

272.52

323.10

u/l

0.58

411

1662

Disorders of lacrimal system

185

934

1.98

17.07

1.2

1.3

330.30

344.26

u/l

0.04

175

858

Open wound of head

223

1156

1.87

17.04

1.2

265.11

349.38

u/l

0.85

209

1068

Appendectomy

274

1499

1.75

17.03

1.3

1.2

231.27

328.32

u/l

1.51

259

1398

Ventral hernia

111

459

2.43

16.98

1.4

1.3

324.31

403.96

u/l

0.30

101

424

Insulin medication

249

1160

1.81

16.93

1.4

1.2

181.44

366.33

u/l

3.93

224

1077

Use of disulfiram, acamprosate or naltrexone

165

3.49

16.73

1.4

1.3

225.29

417.28

u/l

1.33

151

Obesity due to excess calories

206

1091

1.90

16.65

1.3

1.2

252.53

349.20

u/l

0.95

192

1006

Abnormal findings on diagnostic imaging of other body structures

237

3.02

16.51

1.3

292.91

294.76

u/l

0.01

217

Obesity related asthma

156

752

2.08

16.51

1.3

1.2

221.09

409.79

u/l

1.78

147

695

Fracture of rib(s), sternum and thoracic spine

139

642

2.18

16.43

1.3

1.2

201.93

432.04

u/l

2.42

130

595

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

271

1394

1.74

16.42

1.2

1.3

236.49

327.64

u/l

1.25

252

1293

Dermatitis

257

1458

1.76

16.39

1.2

1.3

302.10

330.53

u/l

0.19

235

1365

Acute appendicitis

292

1608

1.70

16.31

1.3

1.2

236.77

341.90

u/l

1.66

274

1501

Kela-code for severe mental illness

161

791

2.04

16.19

1.2

1.3

272.68

355.85

u/l

0.50

147

727

Hypokalaemia

215

3.10

16.02

1.6

1.2

353.12

339.37

u/l

0.03

202

Endocrine, nutritional and metabolic diseases

315

937

1.71

15.76

1.3

1.2

301.74

365.16

u/l

0.43

282

892

Other systemic involvement of connective tissue (FG)

112

475

2.34

15.72

1.4

1.2

274.83

336.95

u/l

0.26

106

433

Hard cardiovascular diseases

328

1176

1.67

15.66

1.3

1.2

239.45

373.81

u/l

1.78

297

1097

Hypertensive diseases

311

1038

1.70

15.61

1.4

1.2

240.07

397.05

u/l

1.97

282

979

Impingement syndrome of shoulder

105

441

2.39

15.56

1.2

340.77

387.26

u/l

0.14

100

410

Heart failure and coronary heart disease

165

574

2.04

15.55

1.2

240.53

440.69

u/l

1.30

159

534

Hypertension

310

1035

1.69

15.53

1.4

1.2

239.74

397.46

u/l

1.98

281

977

Early onset COPD, excluding more controls

346

2.58

15.52

1.5

1.3

197.69

488.31

u/l

1.78

326

Other bacterial intestinal infections

105

443

2.38

15.42

1.2

1.3

205.10

334.84

u/l

1.95

414

Insulin, combination of fast acting with intermediate-acting or long-acting

249

1305

1.75

15.31

1.4

1.2

181.44

354.18

u/l

4.06

224

1211

Disorders of adult personality and behaviour

130

602

2.17

15.30

1.3

212.56

334.73

u/l

1.60

117

559

Other acute lower respiratory infections

219

1155

1.81

15.30

1.3

228.62

358.18

u/l

1.41

203

1061

Nonorganic sleeping disorders, excluding more controls

303

2.69

15.28

1.4

1.2

213.70

313.14

u/l

0.97

276

Chronic apical periodontitis

447

1659

1.54

15.18

1.3

1.2

283.72

320.27

u/l

0.35

415

1553

Heart failure and antihypertensive medication

256

2.54

15.11

1.4

1.1

199.51

617.32

u/l

1.72

242

Insulin, intermediate and long-acting

224

1221

1.79

15.02

1.4

1.2

187.30

354.35

u/l

3.46

200

1132

Finngen Rheumatological endpoints

385

1383

1.59

14.99

1.3

1.2

217.36

352.74

u/l

2.55

364

1291

Other arrhythmias

264

1160

1.72

14.89

1.3

1.2

226.36

358.47

u/l

1.69

241

1085

Other (not insulin) diabetes medications

391

1476

1.57

14.89

1.3

1.2

205.52

353.86

u/l

3.34

360

1382

Hypertensive Heart Disease

103

335

2.42

14.88

1.2

170.97

508.78

u/l

2.03

316

Diseases of salivary glands

141

682

2.08

14.85

1.3

1.2

218.72

327.41

u/l

1.50

125

625

Nutritional anaemias

199

1043

1.84

14.78

1.3

1.2

205.46

325.35

u/l

1.82

188

961

Other joint disorders

342

1106

1.63

14.76

1.3

1.2

196.39

364.31

u/l

3.53

316

1031

Bacterial pneumoniae

172

784

1.94

14.68

1.3

1.2

234.29

363.55

u/l

1.30

164

731

Radiculopathy

216

2.98

14.63

1.4

1.2

193.39

353.56

u/l

2.06

198

Non-invasive ventilation

305

2.56

14.56

1.1

209.52

543.62

u/l

1.59

291

Haemorrhage from respiratory passages

128

538

2.15

14.55

1.1

1.2

172.44

417.02

u/l

3.26

120

504

Autoimmune diseases related-to ILD

342

1843

1.59

14.53

1.3

1.2

254.99

326.21

u/l

0.98

314

1728

Other neurological diseases

287

1357

1.67

14.48

1.2

1.3

243.25

331.11

u/l

1.23

267

1255

Coronary atherosclerosis

250

906

1.75

14.46

1.3

1.2

244.49

356.90

u/l

1.06

226

844

Abnormalities of heart beat

133

623

2.10

14.41

1.3

1.2

251.19

362.65

u/l

0.73

120

585

Acute appendicitis, no complications

232

1327

1.75

14.40

1.4

1.2

233.92

337.68

u/l

1.40

219

1241

Duodenal ulcer

147

3.43

14.36

1.1

205.07

315.15

u/l

1.07

138

Other and unspecified dermatitis

213

1196

1.79

14.34

1.2

1.3

282.45

324.50

u/l

0.28

192

1115

Personality disorders

122

566

2.17

14.33

1.3

270.89

343.97

u/l

0.39

111

525

Hypertension, essential

300

1019

1.67

14.32

1.4

1.2

205.89

400.34

u/l

3.10

272

962

Accidents

320

971

1.65

14.32

1.3

1.2

308.04

296.96

u/l

0.07

297

904

Hypertensive heart and/or renal disease

110

356

2.32

14.30

1.2

169.53

491.38

u/l

2.06

102

335

Unspecified mental disorder

171

897

1.91

14.30

1.2

1.3

263.08

341.18

u/l

0.51

156

823

Benign neoplasm of colon, rectum, anus and anal canal

256

1309

1.70

14.25

1.2

338.45

315.53

u/l

0.07

230

1227

Iron deficiency anaemia

174

906

1.90

14.20

1.4

1.2

189.28

339.27

u/l

2.30

165

830

Other external causes of accidental injury

319

971

1.65

14.12

1.3

1.2

305.40

296.96

u/l

0.05

296

904

Diseases of pulp and periapical tissues, including avohilmo

402

1342

1.55

14.09

1.3

1.2

278.40

341.87

u/l

0.65

370

1253

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

107

3.87

14.04

1.4

1.2

206.69

450.76

u/l

1.15

Specific personality disorders

108

482

2.25

13.97

1.3

217.75

351.18

u/l

1.42

446

Problems related to lifestyle

196

3.03

13.91

1.4

1.2

303.13

366.26

u/l

0.30

187

Mycoses

337

1862

1.58

13.88

1.3

1.2

423.90

295.51

u/l

0.50

309

1747

Pruritus

187

3.07

13.73

1.1

1.2

211.03

286.42

u/l

0.62

173

Erysipelas

283

1315

1.65

13.62

1.3

1.2

275.52

340.12

u/l

0.49

260

1233

Other heart diseases

177

607

1.91

13.62

1.4

1.2

299.08

451.34

u/l

0.90

163

578

Emotionally unstable personality disorder

231

2.83

13.59

1.4

1.3

160.80

327.01

u/l

2.08

213

Cutaneous abscess, furuncle and carbuncle

116

540

2.16

13.54

1.4

1.2

165.87

368.81

u/l

3.65

106

496

Symptoms and signs involving the skin and subcutaneous tissue

281

1690

1.63

13.54

1.3

1.2

210.95

336.61

u/l

2.82

261

1580

Candidiasis

237

2.80

13.53

1.3

1.2

214.81

351.38

u/l

1.05

222

Irregular menses

188

809

1.84

13.45

1.2

1.3

221.07

264.07

u/l

0.46

180

759

Phobic anxiety disorders

222

2.85

13.33

1.2

256.66

312.16

u/l

0.38

208

Oxicams

229

2.44

13.32

1.3

1.2

360.03

251.72

u/l

0.42

216

Other arthrosis

213

832

1.78

13.29

1.2

428.77

385.15

u/l

0.12

204

775

Transport accidents

181

847

1.84

13.23

1.2

228.96

307.30

u/l

0.86

169

788

Somatoform disorder

303

2.56

13.21

1.3

174.11

298.10

u/l

2.25

281

Complications of medical and surgical care

292

1673

1.61

13.19

1.3

194.87

333.38

u/l

3.45

267

1564

Mental and behavioural disorders due to sedatives or hypnotics

112

3.70

13.18

1.2

183.64

411.88

u/l

0.97

103

Arthropathies

346

1108

1.59

13.16

1.3

1.2

202.77

363.78

u/l

3.28

324

1033

Disorders of eyelid, lacrimal system and orbit

335

1633

1.56

12.95

1.2

1.3

274.65

316.68

u/l

0.21

314

1520

Bacterial pneumonia, not elsewhere classified

160

744

1.90

12.90

1.3

240.01

371.94

u/l

1.24

153

693

Infections of the skin and subcutaneous tissue

235

1385

1.68

12.90

1.3

185.47

351.72

u/l

4.46

218

1286

Fall on same level involving ice and snow

229

1355

1.70

12.87

1.5

1.2

255.03

322.28

u/l

0.52

214

1257

Any reimbursement code in KELA

217

610

1.79

12.81

1.4

1.2

258.36

425.30

u/l

1.32

201

576

Biguanides

376

1504

1.53

12.66

1.2

206.78

351.84

u/l

3.27

347

1404

Other and unspecified effects of external causes

119

575

2.08

12.65

1.4

1.2

318.28

294.09

u/l

0.12

109

525

Exposure to other specified factors

296

1717

1.59

12.64

1.5

1.2

391.74

289.11

u/l

0.45

278

1603

ILD medications: immunosuppressive drugs

243

1365

1.66

12.44

1.3

1.2

228.82

331.64

u/l

1.79

225

1271

Bacterial pneumonia (organism specified)

181

914

1.80

12.42

1.3

1.2

236.83

368.18

u/l

1.53

172

844

Diseases of arteries, arterioles and capillaries (FINNGEN)

283

2.33

12.40

1.3

1.2

389.96

579.90

u/l

0.49

269

Other and unspecified iron deficiency

137

703

1.96

12.30

1.4

1.2

183.33

317.11

u/l

2.19

132

640

Acute renal failure

401

2.28

12.20

1.3

1.2

214.59

502.97

u/l

1.88

368

Autoimmune diseases excluding thyroid diseases

406

1485

1.49

12.12

1.4

1.2

307.59

323.55

u/l

0.07

375

1394

Schizophrenia or delusion

131

666

1.97

12.12

1.3

255.39

339.37

u/l

0.58

122

612

Viral infections characterized by skin and mucous membrane lesions

333

1863

1.53

12.07

1.3

1.2

395.63

299.91

u/l

0.39

310

1742

Polycystic ovarian syndrome, consortium definition

267

968

1.64

12.05

1.2

213.53

260.42

u/l

0.63

251

906

Chronic gastritis

102

474

2.16

12.01

1.2

1.1

174.22

404.32

u/l

1.88

444

Schizophrenia, schizotypal and delusional disorders

131

669

1.97

11.97

1.3

255.39

340.31

u/l

0.59

122

614

Hypothyroidism and >3 levothyroxin purchases

195

2.47

11.91

1.2

1.1

313.24

369.32

u/l

0.14

187

Hypothyroidism, levothyroxine purchases

195

2.47

11.91

1.2

1.1

313.24

369.32

u/l

0.14

187

Trochanteric bursitis

231

2.70

11.90

1.6

1.2

568.30

276.09

u/l

0.32

215

Benign neoplasm: Colon

210

1183

1.70

11.89

1.2

361.14

325.66

u/l

0.09

191

1104

Heart failure,strict

201

815

1.75

11.87

1.3

1.2

221.57

361.99

u/l

1.19

191

747

Presence of cardiac and vascular implants and grafts

177

731

1.81

11.83

1.3

1.2

186.84

410.22

u/l

2.70

166

677

Injuries to the knee and lower leg

454

1738

1.45

11.80

1.3

1.2

277.47

323.47

u/l

0.46

430

1618

Unstable angina pectoris

139

566

1.94

11.80

1.2

210.34

443.69

u/l

1.61

134

525

Injury, poisoning and certain other consequences of external causes

193

538

1.80

11.76

1.3

1.2

303.35

331.23

u/l

0.12

182

497

Ischaemic heart disease, wide definition

293

1147

1.59

11.73

1.3

1.2

262.28

369.71

u/l

1.05

265

1070

Injuries to the shoulder and upper arm

324

1708

1.53

11.67

1.3

1.2

310.26

324.77

u/l

0.10

303

1591

Gout

112

477

2.07

11.62

1.3

204.94

500.54

u/l

1.98

106

442

Bipolar affective disorders

360

2.32

11.57

1.3

1.2

288.92

350.65

u/l

0.22

335

Hypothyroidism (congenital or acquired)

195

2.44

11.48

1.2

1.1

310.13

369.32

u/l

0.15

187

Maltreatment syndromes

3.99

11.47

1.6

1.2

271.63

405.03

u/l

0.42

Other CVD (FINNGEN)

131

3.04

11.38

1.5

1.1

252.76

772.84

u/l

0.94

124

Disturbances of skin sensation

114

566

2.02

11.31

1.2

236.09

347.41

u/l

1.17

106

525

Genitourinary diseases

222

654

1.71

11.26

1.2

329.50

367.66

u/l

0.24

205

601

Other enthesopathies

116

583

2.00

11.13

1.3

1.2

475.24

355.44

u/l

0.20

106

543

Medical observation and evaluation for suspected diseases and conditions

266

843

1.62

11.10

1.4

1.2

204.95

389.58

u/l

2.73

233

797

Major coronary heart disease event excluding revascularizations

220

878

1.67

11.10

1.3

1.2

226.27

369.87

u/l

1.48

210

814

Other medical care

188

986

1.72

11.05

1.2

352.23

298.63

u/l

0.28

178

917

Inflammatory diseases of female pelvic organs

226

1009

1.65

11.02

1.2

249.93

250.46

u/l

0.00

207

951

All-cause Heart Failure

217

919

1.67

11.01

1.3

1.2

214.24

362.81

u/l

1.47

206

842

Carpal tunnel syndrome

232

1261

1.63

10.99

1.2

350.45

326.84

u/l

0.07

218

1178

Other systemic involvement of connective tissue

113

566

2.01

10.96

1.4

1.2

274.79

272.96

u/l

0.01

107

518

Heart failure, strict

220

936

1.66

10.94

1.3

1.2

215.54

360.25

u/l

1.45

209

858

Inflammatory bowel disease

131

693

1.90

10.84

1.3

276.52

384.97

u/l

0.72

118

635

Urticaria and erythema

142

771

1.85

10.82

1.2

1.3

217.18

314.06

u/l

1.01

125

709

Autoimmune diseases excluding thyroid diseases, strict definition

389

1451

1.47

10.82

1.3

1.2

312.96

327.27

u/l

0.06

361

1360

Injuries to the abdomen, lower back, lumbar spine and pelvis

160

892

1.78

10.77

1.3

1.2

335.22

374.84

u/l

0.17

153

815

Polyneuropathies and other disorders of the peripheral nervous system

404

2.19

10.75

1.2

277.41

479.15

u/l

0.85

371

Other symptoms and signs involving cognitive functions and awareness

170

885

1.75

10.75

1.1

1.2

230.79

354.26

u/l

0.92

155

822

Volume depletion

149

3.04

10.75

1.2

171.97

298.22

u/l

1.24

141

Enlarged lymph nodes

232

2.60

10.74

1.1

1.2

390.93

303.26

u/l

0.30

214

Disorders of skin appendages

188

1110

1.70

10.71

1.3

260.84

357.43

u/l

1.12

175

1027

Mycoses

111

558

2.00

10.67

1.3

255.55

339.47

u/l

0.64

101

515

Other postsurgical states

119

3.31

10.67

1.3

1.2

269.06

390.74

u/l

0.45

108

Disorders of vestibular function (Vertigo)

181

1042

1.71

10.67

1.2

189.50

356.15

u/l

2.73

171

963

Cerebrovascular diseases (FINNGEN)

113

396

2.02

10.58

1.5

1.1

208.51

536.17

u/l

1.88

105

380

Other and unspecified nonorganic psychotic disorders

382

2.21

10.51

1.3

307.41

373.91

u/l

0.24

353

Obesity, other/unspecified

136

739

1.85

10.37

1.5

1.2

275.58

329.53

u/l

0.30

129

682

Retention of urine

135

595

1.87

10.33

1.4

1.2

242.48

398.25

u/l

1.03

125

552

Systemic connective tissue disorders

134

727

1.85

10.27

1.4

1.2

263.95

256.43

u/l

0.04

125

669

Abnormal involuntary movements

244

2.52

10.22

1.1

1.2

214.06

340.50

u/l

0.91

226

Acute bronchitis

159

892

1.75

10.17

1.3

1.2

234.63

375.92

u/l

1.06

148

813

Any death

237

1065

1.60

10.14

1.2

303.16

350.41

u/l

0.33

221

982

Other anaemias

160

872

1.75

10.13

1.5

1.2

292.93

349.90

u/l

0.30

145

804

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

144

3.01

10.10

1.4

1.3

292.37

366.50

u/l

0.26

133

Gout, FINNGEN

112

576

1.95

10.03

1.3

1.2

204.94

463.61

u/l

1.95

106

536

External causes of morbidity and mortality

233

718

1.63

10.03

1.3

1.2

330.86

299.82

u/l

0.16

220

670

Sleep apnoea, including avohilmo

372

1589

1.45

9.99

1.2

375.76

302.70

u/l

0.31

343

1489

Lesion of ulnar nerve

265

2.43

9.97

1.4

1.2

321.32

367.62

u/l

0.24

245

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

363

1627

1.45

9.93

1.2

236.30

341.18

u/l

1.63

334

1528

Other and unspecified anaemias

158

866

1.74

9.91

1.5

1.2

296.32

351.30

u/l

0.28

143

799

Diplopia

236

2.52

9.90

1.3

1.2

161.26

342.52

u/l

2.26

217

Ulcerative colitis, NAS

248

2.47

9.89

1.5

1.3

349.75

352.25

u/l

0.01

231

Diseases of the respiratory system

228

702

1.63

9.86

1.3

1.2

283.67

345.64

u/l

0.35

208

658

Venous thromboembolism

204

1220

1.62

9.71

1.2

206.97

336.41

u/l

2.38

191

1127

COPD (mode)

110

442

1.96

9.68

1.4

1.2

201.41

422.58

u/l

1.69

102

415

Neoplasms

285

987

1.53

9.65

1.2

1.3

345.14

318.28

u/l

0.16

266

925

Other diseases of upper respiratory tract

409

1500

1.42

9.55

1.2

1.3

348.65

304.77

u/l

0.27

373

1407

Visual disturbances

186

1132

1.65

9.55

1.3

1.2

174.30

348.45

u/l

3.66

172

1045

Other disorders of ear

343

1545

1.46

9.46

1.3

1.2

348.51

314.34

u/l

0.14

325

1434

Symptoms and signs involving the urinary system

286

1453

1.50

9.46

1.4

1.2

230.63

334.40

u/l

1.55

266

1346

Dipeptidyl peptidase 4 (DPP-4) inhibitors

205

1018

1.62

9.43

1.2

204.55

362.59

u/l

2.04

190

943

Chronic laryngitis and laryngotracheitis

248

2.43

9.41

1.2

152.93

272.88

u/l

2.06

227

Viral and other specified intestinal infections

102

503

1.96

9.35

1.3

260.21

303.48

u/l

0.25

470

Injuries to the wrist and hand

371

1805

1.43

9.26

1.4

1.2

375.33

298.99

u/l

0.34

353

1682

Other and unspecified polyneuropathies, also in other diseases

344

2.19

9.25

1.2

302.76

410.00

u/l

0.38

318

Second line medication for Crohn's disease

219

1398

1.57

9.23

1.4

1.2

235.62

328.05

u/l

1.39

204

1301

Other diseases of anus and rectum

469

2.01

9.23

1.1

1.2

209.78

428.10

u/l

1.99

427

Other specified/unspecified arthritis

105

546

1.93

9.22

1.2

336.35

467.02

u/l

0.46

507

Caries of dentine

379

2.11

9.20

1.1

1.3

250.07

340.21

u/l

0.68

361

Disorders of synovium and tendon

183

977

1.64

9.16

1.3

1.2

402.57

301.44

u/l

0.28

164

912

Autoimmune diseases

412

1488

1.41

9.13

1.4

1.2

339.43

323.11

u/l

0.07

374

1397

Aplastic and other anaemias

168

938

1.67

9.09

1.5

1.2

286.18

366.71

u/l

0.48

153

863

Inflammatory disease of uterus

246

2.41

9.09

1.1

1.2

369.18

229.00

u/l

0.37

226

Atrial fibrillation and flutter

109

364

1.95

9.06

1.3

1.2

261.24

590.31

u/l

1.58

102

349

Injuries to the ankle and foot

261

1541

1.51

9.04

1.3

1.2

220.16

331.86

u/l

1.75

247

1439

Other extrapyramidal and movement disorders in other diseases

469

1.99

8.95

1.2

203.15

288.59

u/l

1.07

430

Used for control exclusion in common control thyroid runs

391

1395

1.42

8.94

1.3

1.2

410.79

307.64

u/l

0.45

355

1308

Erysipelas

202

1124

1.59

8.94

1.2

284.65

344.37

u/l

0.32

185

1046

Conductive and sensorineural hearing loss

290

1320

1.48

8.92

1.3

1.2

366.23

329.21

u/l

0.12

271

1222

Artrosis, including avohilmo

303

1120

1.48

8.90

1.3

302.78

341.50

u/l

0.20

282

1041

COPD

162

787

1.69

8.87

1.3

1.2

197.30

405.60

u/l

2.87

151

734

Atrial fibrillation and flutter with reimbursement

281

2.07

8.86

1.3

1.1

255.55

653.95

u/l

1.45

268

Angina pectoris

198

819

1.61

8.82

1.2

243.76

372.34

u/l

1.02

182

762

Urticaria

114

619

1.85

8.79

1.2

1.3

240.39

299.85

u/l

0.45

101

572

Benign neoplasm of other and ill-defined parts of digestive system

345

2.16

8.79

1.4

1.2

188.96

293.12

u/l

1.22

315

Unspecified fall

188

1156

1.61

8.75

1.3

1.2

212.01

352.15

u/l

1.88

179

1059

Sensorineural hearing loss

274

1247

1.49

8.71

1.3

1.2

380.05

334.80

u/l

0.14

255

1156

Dental caries

435

2.00

8.68

1.2

1.3

235.62

317.32

u/l

0.70

417

DVT of lower extremities and pulmonary embolism

154

915

1.68

8.58

1.2

208.42

377.89

u/l

2.38

144

840

Nonorganic sleeping disorders

395

2.06

8.57

1.4

1.3

213.70

304.26

u/l

0.92

364

Gonarthrosis

235

866

1.55

8.53

1.3

1.2

173.14

384.54

u/l

3.64

224

809

Epilepsy

113

616

1.83

8.53

1.1

1.2

340.77

370.46

u/l

0.11

100

566

Necrosis of pulp, including avohilmo

217

1406

1.54

8.51

1.3

186.76

342.99

u/l

4.11

205

1307

Visual disturbances and blindness

194

1229

1.58

8.50

1.3

1.2

175.53

347.81

u/l

3.98

179

1136

148

2.79

8.48

1.1

1.3

460.75

411.89

u/l

0.09

135

All influenza

506

1.92

8.48

1.2

193.13

404.83

u/l

2.00

470

Arthrosis

258

935

1.52

8.47

1.3

1.2

201.51

373.34

u/l

2.78

243

866

Pulmonary heart disease

111

606

1.84

8.43

1.2

213.33

407.13

u/l

1.85

102

553

Renal failure

165

887

1.65

8.41

1.2

213.97

390.03

u/l

1.83

145

824

Generalized anxiety disorder

274

2.27

8.40

1.4

1.2

259.25

277.32

u/l

0.12

257

Pulmonary embolism

111

607

1.83

8.39

1.2

213.33

406.86

u/l

1.85

102

554

Diseases of the ear and mastoid process

423

1538

1.38

8.38

1.3

1.2

330.79

316.70

u/l

0.06

395

1438

Tongue abnormality

106

3.14

8.38

1.2

1.3

274.58

363.19

u/l

0.24

Crohn disease

231

2.39

8.37

1.2

1.3

384.42

359.20

u/l

0.07

214

Diseases of peritoneum

166

2.67

8.37

1.0

1.3

288.72

357.23

u/l

0.29

155

Conjunctivitis (acute, non atopic)

110

599

1.84

8.33

1.3

1.2

206.49

341.31

u/l

1.98

104

548

Viral infections characterized by skin and mucous membrane lesions

159

964

1.65

8.33

1.4

1.2

416.19

320.43

u/l

0.30

149

880

Extrapyramidal and movement disorders

137

801

1.72

8.26

1.3

1.2

288.00

342.86

u/l

0.25

125

737

Adverse effects, not elsewhere classified

381

2.06

8.23

1.4

1.2

227.56

273.69

u/l

0.35

352

Pure hypercholesterolaemia

265

1165

1.49

8.21

1.2

304.93

344.07

u/l

0.15

242

1097

Abnormal findings on diagnostic imaging of lung

171

1017

1.62

8.15

1.1

1.2

188.31

356.46

u/l

2.98

159

940

Early onset COPD

460

1.94

8.03

1.5

1.2

197.69

449.37

u/l

2.15

423

Liquid cancers, helper endpoint

138

711

1.70

7.87

1.3

1.2

295.46

378.71

u/l

0.49

130

656

COPD related to multimorbidity

142

713

1.69

7.86

1.4

1.2

199.01

380.67

u/l

2.24

131

659

Other chronic obstructive pulmonary disease, including avohilmo

191

1010

1.57

7.84

1.4

1.2

206.92

366.39

u/l

2.59

176

941

Umbilical hernia

100

542

1.85

7.82

1.7

1.3

739.28

418.77

u/l

0.46

502

Other arthritis (FG)

116

658

1.77

7.81

1.3

1.2

329.64

433.04

u/l

0.39

106

605

Other special examinations and investigations of persons without complaint or reported diagnosis

250

843

1.50

7.80

1.3

1.2

278.91

389.58

u/l

0.99

225

797

Insulin, fast-acting

134

792

1.70

7.78

1.5

1.2

165.38

408.66

u/l

3.47

116

730

Gonarthrosis [arthrosis of knee](FG)

274

1091

1.46

7.68

1.3

1.2

187.43

379.36

u/l

3.40

258

1017

Other diseases of liver

351

2.06

7.67

1.3

399.84

334.69

u/l

0.20

324

Other chronic obstructive pulmonary disease

151

758

1.65

7.61

1.4

1.2

194.28

411.52

u/l

2.89

140

705

Fissure and fistula of anal and rectal regions

379

2.01

7.61

1.1

1.2

238.97

486.38

u/l

1.75

348

Pulmonary heart disease, diseases of pulmonary circulation

117

671

1.75

7.59

1.2

207.31

383.63

u/l

1.85

108

612

Viral and other specified intestinal infections

364

2.02

7.54

1.3

280.23

300.45

u/l

0.08

340

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

222

1470

1.49

7.54

1.2

1.3

175.14

328.14

u/l

4.23

207

1371

Paroxysmal tachycardia

326

2.01

7.54

1.3

1.2

357.10

519.84

u/l

0.46

309

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

136

811

1.67

7.53

1.3

213.99

327.32

u/l

2.01

128

746

Calculus of kidney and ureter

114

651

1.76

7.52

1.4

1.2

215.46

427.49

u/l

2.10

109

594

Excessive, frequent and irregular menstruation

131

414

1.74

7.44

1.2

1.3

275.50

241.10

u/l

0.16

122

385

All chronic kidney diseases

185

973

1.56

7.44

1.2

201.58

378.65

u/l

2.14

166

896

Unspecified acute lower respiratory infection

296

2.14

7.41

1.3

1.2

179.28

457.87

u/l

2.68

277

Inguinal hernia

205

896

1.53

7.40

1.2

355.34

359.22

u/l

0.01

187

833

Other and unspecified injuries of lower leg

115

2.89

7.31

1.4

1.2

185.79

296.36

u/l

1.24

105

Malignant neoplasm of digestive organs

138

659

1.66

7.13

1.3

1.2

307.91

375.50

u/l

0.32

128

609

Zoster [herpes zoster]

176

1123

1.55

7.06

1.2

347.80

297.32

u/l

0.11

165

1041

Sleep apnoea

336

1577

1.38

7.05

1.2

324.24

316.38

u/l

0.03

308

1478

ILD medications: azathioprine

270

2.16

7.00

1.4

1.2

229.89

334.82

u/l

0.99

246

Ulcerative colitis

519

1.82

6.98

1.4

1.3

291.25

357.74

u/l

0.32

474

Abnormal findings on examination of blood, without diagnosis

168

990

1.56

6.98

1.2

401.77

334.71

u/l

0.18

162

913

Vasomotor and allergic rhinitis

135

809

1.64

6.97

1.1

1.3

262.02

266.11

u/l

0.04

122

753

Azathioprine

271

2.15

6.94

1.4

1.3

229.89

335.75

u/l

1.02

250

Caries of dentine, including avohilmo

277

988

1.43

6.90

1.3

1.2

346.89

329.51

u/l

0.09

255

928

Follicular cysts of skin and subcutaneous tissue

347

2.00

6.80

1.3

1.2

278.00

416.19

u/l

0.78

319

Disease of hard tissues of teeth, NOS

193

658

1.54

6.78

1.2

414.42

284.66

u/l

0.45

179

633

Dissociative [conversion] disorders

3.65

6.76

1.3

1.2

173.57

261.77

u/l

0.48

Persons encountering health services in other circumstances, wide

426

1651

1.33

6.75

1.3

1.2

219.61

341.78

u/l

2.58

384

1556

Paracetamol or NSAID medication

104

2.43

6.71

1.2

426.93

253.52

u/l

0.40

Urolithiasis

118

704

1.68

6.70

1.4

1.2

212.73

412.63

u/l

2.16

113

646

Benign neoplasms

350

1415

1.36

6.67

1.2

434.62

315.41

u/l

0.58

322

1334

L04AX Other immunosuppressants

202

1367

1.48

6.64

1.3

236.42

323.38

u/l

1.21

187

1271

Other and unspecified drugs and medicaments

151

2.53

6.59

1.3

308.91

311.71

u/l

0.01

136

Other cataract

153

733

1.58

6.57

1.2

169.30

419.15

u/l

3.31

147

678

Diseases of the eye and adnexa

288

1024

1.41

6.55

1.4

1.2

249.52

385.70

u/l

1.84

267

963

Diseases of inner ear

192

1249

1.49

6.50

1.3

1.2

193.36

339.20

u/l

2.81

181

1157

Allergic rhinitis

109

636

1.70

6.45

1.1

1.3

270.89

327.78

u/l

0.49

100

590

Blepharochalasis

103

599

1.73

6.45

1.1

1.2

220.13

278.43

u/l

0.38

546

Triptan medication for migraine, single purchase ok

264

1267

1.41

6.43

1.3

1.2

273.24

315.64

u/l

0.38

247

1179

Migraine, single triptan purchase ok & required. ICD-code if available is included

264

1267

1.41

6.43

1.3

1.2

273.24

315.64

u/l

0.38

247

1179

Glucagon-like peptide-1 (GLP-1) analogues

106

623

1.71

6.39

1.4

1.3

170.97

449.12

u/l

3.35

574

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

106

623

1.71

6.39

1.4

1.3

170.97

449.12

u/l

3.35

574

Disorders of lipoprotein metabolism and other lipidaemias

281

1245

1.40

6.39

1.2

323.87

337.26

u/l

0.05

252

1172

Herpesviral [herpes simplex] infections

498

1.79

6.37

1.1

1.3

194.89

279.10

u/l

1.55

460

Dislocation, sprain and strain of joints and ligaments of knee

213

1352

1.45

6.36

1.4

1.2

235.64

330.72

u/l

1.22

201

1255

Insulin, fast-acting or short human

134

839

1.60

6.30

1.5

1.2

165.38

395.46

u/l

3.43

116

775

STROKE

184

831

1.51

6.27

1.2

218.94

402.78

u/l

2.02

168

781

Statin medication

235

918

1.44

6.19

1.3

1.2

226.85

342.98

u/l

1.60

215

862

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

203

1396

1.46

6.16

1.2

1.3

170.60

339.45

u/l

4.62

191

1297

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

152

854

1.55

6.14

1.3

1.2

192.72

263.24

u/l

0.90

147

799

Transient ischemic attack

181

981

1.50

6.13

1.2

244.38

362.73

u/l

1.19

168

903

COPD, hospital admission 2, with asthma infections

111

570

1.67

6.11

1.2

186.10

401.39

u/l

2.18

102

530

Other hearing loss

515

1.75

6.10

1.2

286.91

339.05

u/l

0.18

470

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

181

1186

1.49

6.08

1.2

1.3

205.52

315.91

u/l

2.09

162

1110

All influenza (not pneumonia)

266

2.08

6.07

1.2

254.31

384.13

u/l

1.25

249

Other maternal disorders predominantly related to pregnancy

189

797

1.49

6.01

1.2

1.3

257.40

245.88

u/l

0.07

180

748

Anorexia (incl.atypical)

2.94

5.99

1.7

1.2

218.00

360.69

u/l

0.59

Benign neoplasm: Caecum

177

2.33

5.98

1.2

174.64

335.14

u/l

1.41

165

Injuries to the neck

473

1.78

5.92

1.2

1.3

181.31

333.26

u/l

3.15

436

Other diseases of peritoneum

3.22

5.88

1.1

1.2

266.00

394.84

u/l

0.34

Other and unspecified nerve root and plexus disorders, also in other diseases

388

1.86

5.85

1.3

1.2

246.22

403.58

u/l

1.16

359

Dental caries, including avohilmo

248

897

1.42

5.85

1.3

1.2

347.97

339.87

u/l

0.04

227

840

Chronic rhinitis, nasopharyngitis and pharyngitis

111

680

1.64

5.76

1.2

1.3

247.11

307.10

u/l

0.49

105

629

Dentofacial anomalies [including malocclusion]

239

1375

1.40

5.69

1.3

275.31

326.37

u/l

0.37

217

1289

Other and unspecified urticaria

378

1.86

5.67

1.2

1.3

270.86

298.43

u/l

0.11

348

Oter anti-inflammatory and antirheumatic agents, non-steroids

205

1.92

5.61

1.2

186.69

247.56

u/l

1.13

195

Transplanted organ and tissue status

183

2.25

5.56

1.3

135.67

400.07

u/l

2.84

169

Injury of muscle and tendon at shoulder and upper arm level

128

820

1.57

5.54

1.2

1.3

325.06

380.99

u/l

0.22

119

757

Temporomandibular joint disorders, including avohilmo

149

975

1.51

5.48

1.4

1.2

299.78

267.90

u/l

0.17

140

906

Hyperkinetic disorders, excluding more controls

134

2.44

5.47

1.1

1.2

293.91

276.30

u/l

0.07

125

Other specified and unspecified personality disorders

153

2.37

5.47

1.6

1.3

154.73

403.16

u/l

1.88

143

Colectomy operation

312

1.93

5.46

1.2

276.42

303.29

u/l

0.17

283

Algoneurodystrophy

3.37

5.45

1.6

1.2

217.42

441.55

u/l

0.60

Persistent mood disorders

370

1.84

5.40

1.4

1.3

371.34

353.99

u/l

0.04

343

Menorrhagia

111

374

1.65

5.39

1.1

1.3

177.42

242.39

u/l

0.94

104

348

COPD, early/later onset

152

853

1.50

5.39

1.4

1.2

193.85

389.28

u/l

2.89

141

789

Internal derangement of knee

125

798

1.56

5.38

1.5

1.3

205.76

405.01

u/l

2.67

118

739

Coagulation defects, purpura and other haemorrhagic conditions

364

1.85

5.35

1.4

1.2

238.56

318.90

u/l

0.73

334

Persons encountering health services for specific procedures and health care

376

1736

1.30

5.33

1.2

1.3

403.42

277.23

u/l

0.63

346

1630

Restless leg syndrome

240

2.05

5.29

1.1

1.3

190.98

337.74

u/l

1.53

219

Enteropathic arthropathies

5.06

5.27

1.5

1.3

268.66

639.36

u/l

0.47

Open wound of wrist and hand

149

979

1.49

5.17

1.5

1.2

363.73

352.17

u/l

0.02

143

901

Conduction disorders

464

1.66

5.14

1.3

1.2

246.49

444.12

u/l

1.28

430

Primary gonarthrosis, bilateral

177

1054

1.44

5.09

1.4

1.2

233.64

376.91

u/l

1.22

166

980

Reimbursement for rheumatic diseases

198

1404

1.41

5.09

1.3

290.33

336.27

u/l

0.30

184

1304

COPD, hospital admissions

149

847

1.49

5.07

1.4

1.2

193.25

391.71

u/l

2.92

138

783

Pregnancy hypertension

136

806

1.51

5.05

1.3

204.15

231.89

u/l

0.33

131

753

Disorders of ocular muscles, binocular movement, accommodation and refraction

156

1056

1.47

5.03

1.3

199.42

371.40

u/l

3.06

151

967

Disorders of vitreous body

168

1124

1.45

5.01

1.2

213.87

368.14

u/l

2.13

149

1048

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

331

1622

1.31

5.01

1.3

1.2

252.63

327.55

u/l

0.88

311

1514

Other viral diseases

100

619

1.61

4.98

1.3

389.34

333.12

u/l

0.17

567

Disorders of other endocrine glands

145

962

1.49

4.97

1.4

1.2

237.70

294.26

u/l

0.71

129

886

Congenital malformations of the musculoskeletal system, not elsewhere classified

5.08

4.96

1.1

1.2

221.71

746.52

u/l

0.65

Myocardial infarction

153

727

1.48

4.95

1.2

295.17

390.85

u/l

0.47

148

676

Other diseases of lip and oral mucosa

138

926

1.49

4.88

1.3

1.2

281.98

334.29

u/l

0.28

121

852

Other disorders of eyelid

146

944

1.48

4.83

1.2

200.06

304.88

u/l

1.07

135

868

IBD patients in KELA-register

489

1.68

4.80

1.4

1.3

331.27

377.80

u/l

0.18

446

Persons encountering health services for examination and investigation

231

843

1.38

4.69

1.3

1.2

322.66

389.58

u/l

0.37

211

797

Disorders of the thyroid gland

322

1618

1.30

4.63

1.3

1.2

371.86

306.37

u/l

0.31

299

1510

Disorders of oesophagus in diseases classified elsewhere

6.18

4.61

1.6

1.1

199.05

348.11

u/l

0.35

Contact with and exposure to communicable diseases

675

0.47

4.56

1.1

1.3

481.77

318.50

u/l

0.31

630

Persons encountering health services for specific procedures, not carried out

160

2.20

4.55

1.2

1.3

1958.80

373.17

u/l

0.78

149

Diseases of pulp and periapical tissues and dental caries

214

793

1.38

4.55

1.3

1.2

351.20

345.57

u/l

0.02

193

741

Primary coxarthrosis, bilateral

621

1.58

4.53

1.2

162.63

399.46

u/l

2.75

567

5-aminosalicylic acid

437

1.70

4.52

1.5

1.2

331.83

371.81

u/l

0.14

396

Hypothyroidism, strict autoimmune

249

1224

1.34

4.52

1.2

286.70

309.28

u/l

0.15

228

1147

Diseases of arteries, arterioles and capillaries

216

1171

1.36

4.49

1.2

272.11

345.32

u/l

0.59

194

1087

Disorders of vitreous body and globe

170

1159

1.41

4.48

1.2

215.87

366.44

u/l

2.14

151

1081

Diseases of oral cavity, salivary glands and jaws

187

683

1.41

4.44

1.2

336.44

281.57

u/l

0.29

166

656

Other skin changes

336

1.79

4.42

1.9

1.2

201.49

302.34

u/l

0.99

310

Other and unspecified injuries of ankle and foot

3.02

4.40

1.7

1.1

194.05

462.98

u/l

0.76

Stomatitis and related lesions

388

1.73

4.40

1.1

1.2

194.18

306.56

u/l

1.54

358

L04AD Calcineurin inhibitors

189

2.07

4.39

1.2

1.3

205.30

383.44

u/l

1.40

176

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

137

2.27

4.38

1.1

1.3

327.90

293.46

u/l

0.09

126

Heart failure and bmi 25plus

113

497

1.54

4.37

1.2

221.29

340.76

u/l

0.68

108

455

Benign neoplasm: Rectum, anus and anal canal

383

1.73

4.31

1.3

1.2

248.30

303.06

u/l

0.38

350

Striking against or struck by other objects

111

732

1.52

4.30

1.5

1.3

209.06

398.67

u/l

2.64

104

666

Inflammatory bowel disease, strict (require KELA)

505

1.63

4.29

1.4

1.3

331.27

377.52

u/l

0.19

461

Other abnormal uterine and vaginal bleeding

298

1.71

4.24

1.1

1.3

338.88

253.03

u/l

0.25

274

Endometriosis of pelvic peritoneum

269

1.85

4.21

1.3

543.37

193.66

u/l

0.76

252

Other viral diseases

121

811

1.48

4.20

1.3

355.30

306.85

u/l

0.18

113

747

255

1.89

4.19

1.3

252.07

313.10

u/l

0.44

240

Disorders of lens

225

1046

1.34

4.18

1.2

234.85

398.70

u/l

2.07

204

976

Cardiomyopathy, other and unspecified

115

2.36

4.15

1.3

1.2

244.74

472.84

u/l

0.87

110

Myocardial infarction, strict

138

678

1.45

4.10

1.2

307.48

403.51

u/l

0.42

133

632

Postmenopausal bleeding

274

1.64

4.05

1.1

1.2

300.26

245.93

u/l

0.16

258

Symptoms and signs involving the nervous and musculoskeletal systems

193

1426

1.35

4.05

1.1

1.3

254.86

325.61

u/l

0.71

177

1321

Disorders of sclera, cornea, iris and ciliary body

182

1334

1.37

4.04

1.3

201.00

338.71

u/l

2.83

171

1234

Polyp of the female genital tract

342

1.58

4.01

1.2

1.3

340.24

247.76

u/l

0.38

317

Persons with potential health hazards related to communicable diseases

834

0.56

4.00

1.1

1.3

410.47

317.08

u/l

0.24

774

Car occupant injured in other and unspecified transport accidents

377

1.70

3.99

1.2

1.3

229.67

326.97

u/l

0.71

352

Benign neoplasm: Ascending colon

253

1.86

3.96

1.2

262.52

321.63

u/l

0.30

232

Hypothyroidism, other/unspecified

298

1533

1.28

3.94

1.3

1.2

272.22

305.26

u/l

0.28

275

1432

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

549

1.57

3.94

1.3

176.79

296.32

u/l

2.29

510

Preterm labour and delivery

509

1.59

3.93

1.1

1.2

362.40

219.02

u/l

0.57

475

Other and unspecified disorders of vitreous body

135

932

1.43

3.92

1.2

234.24

358.98

u/l

1.25

122

867

Congenital malformations, deformations and chromosomal abnormalities

210

1456

1.33

3.89

1.2

1.3

372.04

332.30

u/l

0.11

195

1359

Benign neoplasm: Rectum

343

1.73

3.87

1.2

261.72

318.22

u/l

0.35

312

Non-rheumatic valve diseases

144

732

1.42

3.87

1.3

1.2

241.17

393.84

u/l

1.46

133

680

Sequelae of injuries, of poisoning and of other consequences of external causes

496

1.60

3.86

1.2

1.3

304.80

361.05

u/l

0.24

451

Emphysema

101

2.39

3.81

1.1

1.2

234.50

427.24

u/l

0.78

Valvular heart disease excluding rheumatic fever

144

735

1.42

3.80

1.3

1.2

241.17

393.57

u/l

1.46

133

682

Other and unspecified epidermal thickening

3.72

3.80

1.1

110.07

622.66

u/l

1.03

Nonalcoholic fatty liver disease

166

2.06

3.80

1.1

1.3

401.44

344.83

u/l

0.10

154

Chronic kidney disease

597

1.53

3.79

1.2

198.94

400.45

u/l

1.27

558

Osteoporosis with pathological fracture (FG)

108

2.33

3.75

1.2

1.3

149.32

328.57

u/l

1.09

101

Ganglion

354

1.70

3.74

1.3

1.2

363.24

344.75

u/l

0.06

328

Chronic sinusitis

136

962

1.41

3.74

1.1

1.3

191.82

322.98

u/l

1.88

125

897

Hallux valgus (acquired)

105

504

1.50

3.73

1.2

203.87

294.41

u/l

1.45

467

Coxarthrosis

158

752

1.39

3.69

1.2

243.94

391.56

u/l

1.25

147

699

Acetic acid derivatives and related substances

245

1.63

3.69

1.3

1.2

448.33

246.10

u/l

0.71

231

Mouth breathing

133

940

1.42

3.68

1.2

1.3

430.61

344.02

u/l

0.15

126

859

Chronic diseases of tonsils and adenoids

255

1248

1.29

3.66

1.2

1.3

489.75

311.85

u/l

0.67

241

1171

Pacemaker

627

1.50

3.64

1.3

1.2

221.31

377.82

u/l

1.28

578

Hypothyreosis and Thyroxine purchase for inclusion criteria

306

1593

1.26

3.63

1.3

1.2

270.94

321.89

u/l

0.47

282

1489

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

2.88

3.63

1.6

1.3

1720.37

465.84

u/l

0.36

Misadventures to patients during surgical and medical care

254

1.82

3.61

1.3

1.2

174.16

343.43

u/l

2.11

235

Congenital malformations, deformations and chromosomal abnormalities

189

1351

1.33

3.61

1.2

1.3

250.26

338.54

u/l

1.13

175

1258

Elevated blood glucose level

136

2.14

3.60

1.3

165.83

415.01

u/l

1.81

125

Ankylosing hyperostosis [Forestier]

7.87

3.57

1.3

1.8

259.43

225.56

u/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

360

1.67

3.54

1.1

1.2

344.73

340.39

u/l

0.01

330

Noninflammatory disorders of female genital tract

121

418

1.45

3.48

1.2

1.3

301.86

240.17

u/l

0.29

112

388

Bicipital tendinitis

2.62

3.47

1.2

206.00

495.72

u/l

1.04

Other disorders of skin and subcutaneous tissue

224

1538

1.30

3.46

1.3

1.2

205.15

340.64

u/l

2.61

195

1443

Focal epilepsy, strict definition

378

1.64

3.45

1.1

1.3

340.35

340.20

u/l

0.00

346

Malignant neoplasm, wide definition for exclusion

294

1369

1.26

3.44

1.2

1.3

312.23

325.82

u/l

0.08

277

1275

Unspecified haematuria

134

795

1.40

3.42

1.5

1.2

253.69

394.54

u/l

1.26

124

739

Fracture of lower leg, including ankle

176

1307

1.33

3.42

1.3

1.2

301.84

349.78

u/l

0.26

161

1208

COPD, hospital admissions 3, with asthma pneumonia sepsis

442

1.55

3.41

1.3

1.2

180.94

426.14

u/l

1.86

408

Vulvovaginal ulceration/inflammation in other diseases

2.35

3.41

1.1

1.3

143.64

250.76

u/l

1.25

Other diseases of hard tissues of teeth

178

682

1.35

3.40

1.3

1.2

304.25

281.43

u/l

0.11

165

655

Subjective visual disturbances

553

1.52

3.39

1.3

1.2

150.88

330.30

u/l

4.85

508

Other inflammatory liver diseases

107

2.25

3.38

1.5

1.4

1468.83

358.56

u/l

0.44

Persons encountering health services in other circumstances

128

912

1.40

3.34

1.3

1.2

251.53

365.37

u/l

0.82

113

851

Haemorrhage in early pregnancy

533

1.52

3.31

1.3

285.00

229.28

u/l

0.48

496

Glomerular diseases

337

1.67

3.30

1.2

145.44

370.46

u/l

3.71

309

Diseases of the myoneural junction and muscle

204

1.87

3.29

1.2

1.3

490.76

346.77

u/l

0.22

191

Speech therapy

561

0.52

3.27

1.1

1.3

217.45

323.40

u/l

1.50

514

Triptan medication for migraine, min. 3 purchases

180

1036

1.33

3.27

1.4

1.2

275.79

274.01

u/l

0.01

169

973

Other fall from one level to another

455

1.56

3.24

1.3

299.55

366.95

u/l

0.26

421

Pneumonitis due to solids and liquids

129

2.10

3.23

1.4

1.3

225.83

411.11

u/l

1.04

120

Nail disorders

130

2.09

3.17

1.1

1.3

139.67

399.50

u/l

1.91

117

Periapical abscess

147

1088

1.35

3.17

1.3

242.88

359.83

u/l

1.45

132

1008

Acute appendicitis, with complications

372

1.62

3.16

1.2

1.3

248.13

434.73

u/l

1.46

342

Undetermined asthma, excluding more controls

214

1.83

3.16

1.2

1.3

229.88

319.32

u/l

0.39

203

Exclusions for E4_PCOS_CONSORTIUM

230

1125

1.28

3.15

1.3

1.2

265.51

291.91

u/l

0.20

212

1055

Drug-induced cataract

3.28

3.15

1.2

195.46

594.40

u/l

0.79

Nontoxic goitre/thyroid nodule

605

1.47

3.11

1.8

1.2

277.99

230.83

u/l

0.18

557

Gonarthrosis,primary

293

1453

1.24

3.11

1.3

1.2

211.41

344.81

u/l

2.00

274

1355

Focal epilepsy

421

1.57

3.09

1.1

1.2

333.40

322.63

u/l

0.03

384

Undetermined asthma

216

1.81

3.08

1.2

1.3

229.88

319.73

u/l

0.40

204

Disorders of breast

151

1022

1.34

3.07

1.2

177.91

258.24

u/l

1.51

142

958

Other and unspecified myopathies

139

2.02

3.05

1.1

1.2

616.91

388.18

u/l

0.25

127

Somnolence, stupor and coma

2.59

3.04

1.3

1.2

132.41

445.30

u/l

1.11

Dialysis, with operation codes

225

1.78

3.01

1.2

204.38

392.39

u/l

1.36

207

Familial hypercholesterolemia, with ischemic heart disease

133

2.04

3.00

1.3

1.1

168.27

385.53

u/l

1.46

123

Endometriosis

395

1.46

2.99

1.2

1.3

379.07

244.32

u/l

0.48

368

Familial hypercholesterolemia

278

1.70

2.98

1.3

1.2

215.95

446.05

u/l

1.12

261

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

324

1.64

2.97

1.5

1.3

228.74

334.04

u/l

1.12

301

Caries of enamel

192

1776

0.78

2.95

1.2

1.3

370.71

313.83

u/l

0.16

174

1661

Malignant neoplasm

280

1335

1.24

2.95

1.2

1.3

300.54

328.88

u/l

0.20

264

1243

Papulosquamous disorders

127

931

1.37

2.94

1.2

303.71

366.81

u/l

0.28

113

863

Colonic or urogenital fistula

564

1.47

2.93

1.1

1.3

237.11

350.65

u/l

1.26

516

Sulfasalazine

597

1.46

2.92

1.2

296.97

340.65

u/l

0.23

545

Viral warts

428

1.55

2.91

1.2

1.3

220.17

299.19

u/l

0.88

394

Other contact dermatitis

135

2.01

2.90

1.4

1.2

180.78

310.35

u/l

0.85

125

Ehlers-Danlos syndrome

4.15

2.89

1.2

232.33

976.94

u/l

—

Endometriosis ASRM stages 1,2

335

1.62

2.87

1.3

522.77

228.75

u/l

0.63

309

Coxarthrosis [arthrosis of hip](FG)

167

895

1.31

2.86

1.2

236.05

402.87

u/l

1.58

155

829

Dental operations

200

796

1.29

2.86

1.3

1.2

304.21

355.26

u/l

0.25

174

766

Meniscus derangement

169

868

1.31

2.85

1.2

272.02

386.18

u/l

1.01

154

807

Other diseases of pleura

137

894

1.34

2.83

1.2

212.38

358.71

u/l

1.58

123

826

Other diseases of spinal cord

2.79

2.82

1.1

1.3

181.69

511.86

u/l

0.79

Other diseases of the respiratory system

368

1.58

2.82

1.2

278.71

294.17

u/l

0.05

332

Other respiratory disorders and diseases

368

1.58

2.82

1.2

278.71

294.17

u/l

0.05

332

Factors influencing health status and contact with health services

333

1.45

2.78

1.4

1.2

420.62

393.27

u/l

0.07

317

Other disorders of breast and lactation associated with childbirth

3.95

2.78

1.1

1.0

187.78

342.78

u/l

—

Medical abortion

194

818

1.29

2.75

1.2

201.92

264.57

u/l

0.86

178

770

Inflammatory disorders of breast

104

2.12

2.74

1.3

1.2

200.73

316.67

u/l

0.52

Acute suppurative otitis media

475

1.48

2.67

1.2

1.3

342.91

292.27

u/l

0.19

440

Primary_lymphoid and hematopoietic malignant neoplasms

486

1.48

2.66

1.3

1.2

200.57

425.69

u/l

1.56

446

Mental and behavioural disorders due to cannabinoids

2.81

2.65

1.4

1.2

200.58

651.61

u/l

0.89

Complications of labour and delivery

180

776

1.29

2.63

1.2

279.84

246.63

u/l

0.20

166

729

Puerperal sepsis

243

1.69

2.62

1.3

1.2

166.29

233.46

u/l

1.08

222

Coronary artery bypass grafting

342

1.51

2.62

1.1

153.42

521.87

u/l

2.38

323

Injuries to the hip and thigh

145

1000

1.31

2.61

1.3

1.2

379.17

339.61

u/l

0.14

136

919

Excessive vomiting in pregnancy

134

1.95

2.60

1.2

1.3

511.19

237.57

u/l

0.36

123

Female genital prolapse

317

1.46

2.60

1.2

1.3

298.26

252.43

u/l

0.16

295

Cerebral atherosclerosis

4.70

2.60

1.0

437.14

149.93

u/l

—

Non-ischemic cardiomyopathy

464

1.44

2.59

1.4

1.2

299.79

408.16

u/l

0.34

430

Disorders of conjunctiva

261

1712

1.22

2.58

1.5

1.2

212.28

335.39

u/l

2.82

249

1593

Propionic acid derivatives

265

1.48

2.56

1.2

445.71

247.18

u/l

0.65

249

Suppurative and unspecified otitis media

103

662

1.38

2.55

1.5

1.3

248.08

320.65

u/l

0.64

614

Female infertility

323

1.47

2.54

1.2

1.3

219.38

201.28

u/l

0.23

303

Psoriasis vulgaris

378

1.54

2.54

1.2

325.06

413.25

u/l

0.29

347

Residual foreign body in soft tissue

2.23

2.54

1.5

1.2

338.86

564.81

u/l

0.54

Missing teeth due to accident, extraction or parodontitis

185

1377

1.27

2.54

1.2

293.54

342.72

u/l

0.29

159

1289

Other follicular disorders

108

2.04

2.51

1.2

1.3

240.77

442.96

u/l

0.94

Conjunctivitis

234

1585

1.23

2.51

1.5

1.2

214.50

342.41

u/l

2.64

222

1475

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

372

1.54

2.49

1.4

1.3

233.65

393.15

u/l

1.38

342

Mild mental retardation

2.99

2.49

1.1

134.36

551.65

u/l

0.78

Focal brain injury

2.20

2.47

1.2

1.3

240.17

340.49

u/l

0.50

Type 1 diabetes

503

1.45

2.45

1.6

1.2

165.97

494.32

u/l

2.73

462

Deviated nasal septum

100

729

1.37

2.44

1.2

1.3

489.38

371.72

u/l

0.16

677

Ulcerative colitis (strict definition, require KELA)

342

1.55

2.44

1.5

1.3

228.74

383.36

u/l

1.23

316

Other epidermal thickening

2.25

2.44

1.1

1.2

115.94

527.57

u/l

1.73

Psoriasis

621

1.40

2.43

1.2

274.74

392.46

u/l

0.62

574

Benign mammary dysplasia

272

1.62

2.42

1.2

161.51

260.01

u/l

0.98

248

Supplementary factors related to causes of morbidity and mortality classified elsewhere

689

1.38

2.42

1.3

1.2

557.08

334.50

u/l

0.34

636

Conductive hearing loss, unspecified

138

1.89

2.40

1.3

1.2

161.62

332.27

u/l

1.23

127

Nephropathy related operations

219

1.69

2.40

1.2

1.3

201.72

395.18

u/l

1.33

200

Exclusions for E4_PCOS_BROAD

328

1.56

2.38

1.8

1.3

199.80

343.98

u/l

1.64

302

Persons encountering health services for other counselling and medical advice, not elsewhere classified

359

1649

1.18

2.38

1.4

1.2

214.45

341.79

u/l

2.64

327

1554

Viral pneumonia

220

1.69

2.37

1.1

1.3

220.53

356.44

u/l

0.75

202

Other noninflammatory disorders of uterus, except cervix

267

1.52

2.35

1.3

1.2

163.42

264.17

u/l

1.13

248

Rubella [German measles]

2.27

2.35

1.0

1.2

1356.69

550.53

u/l

0.30

Hypothyroidism, strict autoimmune, 3 medication purchases required

265

1478

1.21

2.34

1.2

284.91

325.53

u/l

0.31

244

1379

Anankastic personality disorder

2.32

2.31

1.1

1.2

414.73

423.42

u/l

0.01

Gingivitis and periodontal diseases

338

1470

1.19

2.30

1.2

1.3

288.66

305.62

u/l

0.14

306

1381

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

637

1.38

2.29

1.4

1.3

259.05

373.06

u/l

0.81

586

Cerebrovascular diseases

225

1289

1.23

2.28

1.4

1.2

193.12

343.36

u/l

3.31

209

1194

Diffuse large B-cell lymphoma, including Hilmo

2.28

2.24

1.1

1.2

141.47

438.82

u/l

1.16

Diffuse large B-cell lymphoma

2.28

2.24

1.1

1.2

141.47

438.82

u/l

1.16

Diffuse large B-cell lymphoma, helper endpoint

2.28

2.24

1.1

1.2

141.47

438.82

u/l

1.16

Motorcycle rider injured in other and unspecified transport accidents

2.10

2.22

1.4

216.72

565.63

u/l

1.32

Golimumab

2.35

2.22

1.3

1.2

155.07

432.23

u/l

0.85

367

1.49

2.21

1.3

1.2

179.17

262.24

u/l

0.88

343

Hordeolum and other deep inflammation of eyelid

2.05

2.21

1.1

1.3

234.94

459.62

u/l

0.85

Complications of genitourinary prosthetic devices, implants and grafts

2.88

2.21

1.2

1.1

331.80

335.27

u/l

—

Fracture at wrist and hand level

102

760

1.34

2.19

1.4

1.2

559.42

381.51

u/l

0.27

692

Rheumatoid arthritis

590

1.37

2.19

1.3

1.2

277.11

429.63

u/l

0.88

546

Dermatophytosis

185

1492

1.24

2.18

1.2

1.3

604.19

310.53

u/l

0.67

167

1396

Disorders of choroid and retina

250

1474

1.21

2.16

1.3

1.2

251.00

344.73

u/l

0.86

225

1377

Postmenopausal osteoporosis with pathological fracture

2.03

2.16

1.3

1.2

133.42

309.85

u/l

0.91

Etanercept

108

1.95

2.15

1.1

1.3

196.43

347.82

u/l

0.77

Keratitis

105

791

1.33

2.14

1.3

171.15

399.00

u/l

3.32

100

723

Vestibular neuronitis

152

1.78

2.11

1.5

1.3

207.67

343.31

u/l

0.94

140

Ulcerative colitis (strict definition, all Crohn cases excluded)

283

1.56

2.10

1.6

1.3

201.34

340.48

u/l

1.47

264

Ingrowing nail

2.14

2.08

1.1

1.3

94.56

516.72

u/l

1.73

Anti-inflammatory and antirheumatic products, non-steroids

265

1.42

2.08

1.2

472.43

247.18

u/l

0.75

249

Atherosclerosis, excluding cerebral and coronary sclerosis

118

716

1.31

2.07

1.2

203.66

388.49

u/l

1.94

103

663

Senile cataract

184

910

1.24

2.05

1.2

253.84

409.29

u/l

1.51

166

851

Atrophic disorders of skin

293

1.54

2.05

1.1

1.3

138.84

306.06

u/l

2.43

269

Scabies

2.18

2.04

1.4

1.3

112.00

442.28

u/l

1.46

Calcific aortic valvular stenosis, including rheumatic fever

564

1.38

2.04

1.2

178.26

400.74

u/l

2.20

525

Abnormalities of forces of labour

169

1.72

2.03

1.3

163.83

226.38

u/l

0.85

157

Assault by unspecified means

2.65

2.01

1.2

443.70

504.73

u/l

—

Other diseases of blood and blood-forming organs, wide

450

1.42

2.00

1.6

1.2

396.68

320.45

u/l

0.25

412

Injuries to the elbow and forearm

216

1571

1.21

2.00

1.3

1.2

226.73

336.93

u/l

1.52

204

1454

Postprocedural musculoskeletal disorders, not elsewhere classified

126

1.83

1.98

1.2

181.43

400.11

u/l

1.37

116

Diseases of male genital organs

154

615

1.26

1.98

1.2

1.3

530.88

373.91

u/l

0.33

142

571

Postmenopausal atrophic vaginitis

277

1.42

1.97

1.2

1.3

154.86

253.88

u/l

1.24

260

Wet age-related macular degeneration

288

1.52

1.93

1.2

435.84

276.43

u/l

0.31

273

Other and unspecified mononeuropathies, also in other diseases

2.46

1.93

1.2

384.91

568.35

u/l

0.29

Other enthesopathy of foot (+metatarsalgia)

150

1.74

1.90

1.2

171.19

381.36

u/l

1.65

142

Calcific aortic valvular stenosis, diagnosis (helper)

564

1.36

1.90

1.2

179.40

400.74

u/l

2.18

525

Operations 2 for CAVS

564

1.36

1.90

1.2

179.40

400.74

u/l

2.18

525

Iridocyclitis

456

1.41

1.88

1.2

1.3

202.71

331.05

u/l

2.04

416

Dislocation, sprain and strain of joint and ligaments of hip

2.32

1.88

1.3

1.1

192.58

293.34

u/l

0.45

Embedded and impacted teeth

396

1.40

1.86

1.2

1.3

799.37

338.37

u/l

0.47

366

Calcific aortic valvular stenosis, operated

566

1.35

1.86

1.2

179.40

400.21

u/l

2.18

527

Calcific aortic valvular stenosis

566

1.35

1.86

1.2

179.40

400.21

u/l

2.18

527

Major anomalies of jaw size

2.41

1.85

1.2

1.1

204.36

540.18

u/l

0.74

D07AA Corticosteroids, weak (group I)

292

1.51

1.85

1.3

180.89

320.95

u/l

1.60

270

Cellulitis

450

1.40

1.84

1.3

1.2

163.26

383.69

u/l

2.99

413

Other disorders of conjunctiva

253

1.54

1.83

1.2

179.10

311.33

u/l

1.39

229

Other and/or unspecified nontoxic goitre

145

1.73

1.81

2.5

1.2

159.12

290.44

u/l

0.98

130

Sequelae of injuries of head

1.96

1.80

1.4

1.3

162.65

402.14

u/l

1.15

Diabetic retinopathy, strict definition

399

0.62

1.79

1.1

1.3

91.09

216.43

u/l

4.64

369

Lichen planus

231

1.56

1.78

1.1

1.3

424.43

275.25

u/l

0.23

213

Motorcycle rider injured in noncollision transport accidents

2.35

1.78

1.3

1.1

201.64

688.24

u/l

1.10

Solid cancers, helper endpoint

264

1324

1.18

1.77

1.2

1.3

321.58

327.81

u/l

0.04

250

1232

Exposure to other and unspecified inanimate mechanical forces

124

1.78

1.75

1.1

1.3

281.50

403.11

u/l

0.53

112

Pediculosis, acariasis and other infestations

1.90

1.75

1.3

96.72

453.67

u/l

2.09

Metatarsalgia

139

1.73

1.75

1.2

174.32

364.50

u/l

1.33

132

Other symptoms and signs involving the nervous and musculoskeletal systems

123

978

1.26

1.73

1.1

1.3

278.33

367.47

u/l

0.59

110

899

Other and unspecified follicular disorders

2.14

1.71

1.2

1.3

230.38

465.19

u/l

0.67

Atopic dermatitis

166

1117

1.22

1.70

1.2

1.3

193.87

335.78

u/l

2.49

151

1047

Atopic dermatitis, strict definition with reimbursement

591

1.32

1.68

1.2

1.3

178.68

313.97

u/l

2.26

550

Stroke, including SAH

183

1101

1.21

1.67

1.3

1.2

192.25

355.28

u/l

2.96

171

1017

Car occupant injured in noncollision transport accident

2.19

1.67

1.3

323.42

638.94

u/l

0.58

Peripheral arterial reconstruction

300

1.47

1.67

1.1

1.2

144.16

392.08

u/l

1.93

277

Disturbances of smell and taste

2.11

1.65

1.2

1.3

189.00

474.95

u/l

0.98

Other specified/unspecified soft tissue disorders

2.04

1.64

1.0

1.2

469.50

443.89

u/l

0.04

Otitis externa

452

1.37

1.64

1.3

759.41

340.42

u/l

0.36

411

Glucosamine medication

134

863

1.24

1.63

1.2

380.06

332.61

u/l

0.09

127

792

Raynaud syndrome

150

1.67

1.63

1.1

1.3

535.36

336.53

u/l

0.28

137

Anosmia

3.08

1.61

1.3

1.1

172.50

274.21

u/l

—

Fibroblastic disorders

420

1.38

1.60

1.4

1.2

835.98

379.65

u/l

0.42

389

Covid-19 confirmed case

106

838

1.27

1.59

1.7

1.2

194.76

379.20

u/l

2.22

770

Herpesviral [herpes simplex] infections

206

1.56

1.59

1.2

220.15

294.93

u/l

0.62

192

Event of undetermined intent

106

1.80

1.58

1.4

1.3

325.63

431.35

u/l

0.30

Foreign body or object entering through skin

1.82

1.57

1.1

1.3

142.11

435.96

u/l

1.56

Mumps

2.29

1.56

1.0

1.3

184.90

569.72

u/l

—

Seropositive rheumatoid arthritis

489

1.35

1.55

1.4

1.2

279.93

365.61

u/l

0.37

448

Contusion of other and unspecified parts of foot

1.89

1.55

1.2

135.94

464.11

u/l

1.42

Cysts of oral region, not elsewhere classified

1.83

1.51

1.3

1.2

350.94

453.06

u/l

0.23

Injury of nerves at wrist and hand level

2.17

1.50

1.2

133.00

324.32

u/l

1.55

Varicose veins

183

1161

1.19

1.50

1.3

1.2

248.53

338.07

u/l

0.88

171

1080

Allergic contact dermatitis

250

1.48

1.49

1.1

1.3

158.55

268.80

u/l

1.55

232

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

1.95

1.49

1.0

1.3

244.21

421.30

u/l

0.58

498

1.31

1.48

1.3

1.2

314.66

287.76

u/l

0.07

465

Other degenerative diseases of the nervous system

355

1.35

1.47

1.2

186.44

333.16

u/l

1.21

340

Unspecified event, undetermined intent

2.38

1.46

1.4

1.1

437.22

594.28

u/l

—

Contact with machinery

203

1.53

1.45

1.2

243.61

491.06

u/l

1.98

185

Disturbance of activity and attention

207

1.52

1.44

1.1

1.3

288.09

368.40

u/l

0.33

189

Other infectious diseases

148

1.63

1.44

1.2

1.3

242.33

395.45

u/l

0.74

134

Type 1 diabetes, wide definition, subgroup 1

352

1.39

1.44

1.2

134.43

250.53

u/l

3.48

329

Hyperkinetic disorders

223

1.50

1.43

1.1

1.3

293.91

366.94

u/l

0.32

202

Invasive ventilation

125

1.68

1.43

1.4

1.2

230.14

424.33

u/l

0.96

114

Other infectious diseases

125

1.68

1.43

1.2

221.86

352.26

u/l

0.55

112

Rheumatoid arthritis, including avohilmo

105

844

1.25

1.41

1.2

292.94

310.65

u/l

0.09

777

Benign neoplasm: Skin of eyelid, including canthus

287

1.43

1.40

1.3

1.2

194.47

300.18

u/l

1.12

265

Pneumonia derived septicemia

2.18

1.40

1.5

1.2

134.20

505.93

u/l

—

Lesion of plantar nerve

1.78

1.39

1.3

1.2

235.12

348.75

u/l

0.37

Spasmodic torticollis

2.09

1.38

1.4

1.2

1083.09

296.83

u/l

0.44

Fracture of femur

462

1.32

1.37

1.2

324.23

279.05

u/l

0.17

427

Other encephalitis

2.20

1.37

1.2

1.1

416.22

483.08

u/l

—

Redundant prepuce, phimosis and paraphimosis

420

1.35

1.37

1.3

236.22

423.98

u/l

1.97

384

Other puerperal infections

135

1.63

1.35

1.1

1.2

161.14

272.98

u/l

1.39

121

Visual field defects

143

1.61

1.35

1.1

1.2

200.13

389.12

u/l

0.93

129

Diseases of external ear

761

1.25

1.33

1.2

538.72

355.96

u/l

0.23

701

Stroke, excluding SAH

169

1044

1.18

1.31

1.3

1.2

190.26

362.88

u/l

2.97

158

961

Use of interferon beta-1a

0.00

1.31

0.0

1.2

—

564.03

—

Mental retardation

1.96

1.30

1.1

1.3

134.08

416.30

u/l

0.95

Encephalitis

2.10

1.30

1.2

416.22

474.16

u/l

—

Presence of other devices

471

1.31

1.28

1.2

325.88

410.62

u/l

0.25

433

Schizotypal disorder

2.06

1.27

1.1

1.3

183.22

649.53

u/l

—

Benign neoplasm of other and unspecified sites

2.01

1.23

1.1

126.56

517.05

u/l

—

Other and unspecified corneal deformities and disorders

1.97

1.22

1.4

1.1

107.73

478.78

u/l

1.20

Any event in cancer register

285

1484

1.13

1.21

1.2

1.3

299.28

319.35

u/l

0.15

267

1384

Dislocation, sprain and strain of joints and ligaments of elbow

109

1.66

1.18

1.7

1.2

216.56

400.09

u/l

0.72

COPD, hospital admissions 1, only main diagnosis

623

1.24

1.17

1.5

1.2

180.20

375.13

u/l

2.14

575

Maternal care for other known or suspected fetal problems

307

1.30

1.17

1.2

227.62

227.34

u/l

0.00

288

Mental retardation, wide definition

1.87

1.16

1.1

1.3

134.08

412.86

u/l

1.01

Lichen planus, including avohilmo

387

1.32

1.12

1.1

1.3

347.93

288.01

u/l

0.12

361

Diseases of middle ear and mastoid

156

1093

1.17

1.11

1.4

1.3

255.10

353.40

u/l

1.03

144

1007

Peripheral artery disease

116

771

1.20

1.11

1.1

1.2

187.65

399.47

u/l

2.39

100

713

Presence of other functional implants

161

958

1.17

1.10

1.2

220.43

365.12

u/l

1.88

149

892

Sub-endpoint used in defining T1D endpoints

609

1.24

1.09

1.5

1.2

170.72

341.09

u/l

2.24

557

Other respiratory diseases principally affecting the interstitium

320

1.35

1.08

1.1

1.2

233.83

305.13

u/l

0.60

291

Type of accident

647

1.24

1.08

1.4

1.2

603.94

342.92

u/l

0.34

599

Retinal detachment with retinal break

235

1.41

1.08

1.1

1.2

425.82

345.95

u/l

0.14

216

Polyarthritis, unspecified

1.87

1.07

1.7

1.3

757.09

465.73

u/l

0.21

Convergent concomitant strabismus

1.65

1.06

1.4

1.3

202.19

380.60

u/l

0.80

Non-follicular lymphoma

162

1.48

1.04

1.3

1.2

158.21

363.49

u/l

1.79

150

Prolonged pregnancy

253

0.66

1.03

1.1

1.2

192.74

225.66

u/l

0.34

235

Bitten or struck by other mammals

212

1.42

1.03

1.1

1.3

158.23

328.61

u/l

2.11

197

Haemangioma, any site

154

1.50

1.03

1.3

161.83

310.72

u/l

1.32

140

Myocardial infarction, unclassifiable

358

1.30

1.03

1.2

353.25

330.84

u/l

0.05

328

Abnormal findings on examination of urine, without diagnosis

1.74

1.02

1.2

530.46

412.82

u/l

0.20

Fall involving bed

1.92

1.02

1.1

56.00

420.38

u/l

—

Maternal care for known or suspected fetal abnormality and damage

258

0.67

1.02

1.2

227.60

238.10

u/l

0.07

239

Use of donepezil

343

0.70

1.02

1.0

1.2

201.44

278.42

u/l

0.81

318

Chondromalacia

1.88

1.00

1.0

1.3

221.22

486.26

u/l

—

Pneumococcal septicemia

1.88

1.00

1.6

1.2

135.11

526.29

u/l

—

Hyperlipidaemia, other/unspecified

103

794

1.19

1.00

1.1

1.2

230.89

342.68

u/l

0.99

744

conjunctival haemorrhage

123

1.55

0.99

1.3

1.2

188.53

394.69

u/l

1.13

113

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

1.84

0.98

2.1

1.2

858.33

414.24

u/l

—

Ischaemic Stroke, excluding all haemorrhages

153

987

1.15

0.96

1.2

178.42

362.19

u/l

3.17

143

907

Anogenital herpesviral [herpes simplex] infection

199

1.41

0.95

1.1

1.3

177.46

307.35

u/l

1.35

180

Amiodarone users

174

1.44

0.95

1.4

1.2

192.20

411.22

u/l

1.84

162

Anomalies of dental arch relationship, including avohilmo

360

1.28

0.92

1.3

190.44

333.29

u/l

2.34

336

Other pulmonary heart/vessel disease

1.72

0.92

1.1

1.2

121.67

382.00

u/l

1.03

Retinal detachments and breaks

807

1.19

0.92

1.2

255.71

374.14

u/l

0.71

750

Third [oculomotor] nerve palsy

2.15

0.91

1.8

1.1

205.83

662.65

u/l

—

Other retinal disorders

173

1185

1.14

0.91

1.3

1.2

245.12

341.95

u/l

0.72

156

1100

Disorders of optic nerve and visual pathways

159

1.45

0.91

1.1

1.3

283.74

391.94

u/l

0.51

145

Secondary right heart disease

1.75

0.90

1.1

1.2

124.55

407.47

u/l

0.99

Other obstructive and reflux uropathy

1.75

0.90

2.1

1.2

304.45

402.76

u/l

0.20

Benign neoplasm of meninges

177

1.41

0.88

1.2

1.3

167.70

256.02

u/l

0.66

162

Agranulocytosis

194

1.39

0.88

1.2

416.77

296.56

u/l

0.17

180

Portal vein thrombosis

2.01

0.87

1.8

1.3

126.50

695.84

u/l

—

Tonsillectomy and adenotomy

152

925

1.14

0.86

1.2

1.3

287.37

320.38

u/l

0.25

144

861

Other menopausal disorders

296

1.24

0.86

1.2

1.3

397.57

218.45

u/l

0.56

277

Benign lipomatous neoplasm of other sites/unspecified

145

1.45

0.84

1.2

1.3

517.05

326.93

u/l

0.29

135

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

1.78

0.84

1.5

1.2

262.38

494.46

u/l

—

Procreative management

623

0.82

0.84

1.8

1.3

218.04

321.41

u/l

1.21

584

Unspecified kidney failure

162

1.42

0.84

1.2

139.53

351.53

u/l

1.91

154

Artificial joint operation, meniscal resection

271

1596

1.10

0.83

1.3

1.2

204.21

347.74

u/l

3.46

253

1486

Lichen ruber planus, wide definition including periferal and oral lichen planus

461

1.24

0.83

1.1

1.3

321.28

319.36

u/l

0.00

426

Follow-up examination after treatment for conditions other than malignant neoplasms

124

710

1.16

0.82

1.2

257.25

401.61

u/l

1.12

108

668

Maternal care related to the fetus and amniotic cavity and possible delivery problems

118

597

1.16

0.81

1.3

1.2

265.94

222.14

u/l

0.22

111

566

Hyperplasia of prostate

467

1.18

0.81

1.2

1.3

696.81

355.12

u/l

0.51

435

Insulin, fast-acting (human)

241

1.33

0.80

1.1

1.3

74.89

394.90

u/l

5.36

220

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

147

1.43

0.80

1.1

1.2

133.71

279.82

u/l

1.21

132

Chronic periodontitis, including avohilmo

287

1756

1.10

0.79

1.1

1.3

353.20

310.68

u/l

0.31

265

1642

L02BB Anti-androgens

147

0.61

0.79

1.1

206.67

288.40

u/l

—

136

Chronic periodontitis, complicated

152

1334

1.13

0.77

1.1

1.2

357.39

328.62

u/l

0.14

140

1239

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.77

0.76

1.0

1.1

196.00

637.43

u/l

—

In situ neoplasms

834

0.84

0.76

1.2

202.18

284.20

u/l

0.91

769

Benign neoplasm: Skin of other and unspecified parts of face

183

1.37

0.75

1.0

1.2

640.37

324.23

u/l

0.30

170

Benign neoplasm of thyroid gland

1.70

0.75

1.3

1.1

208.33

463.17

u/l

—

Examination and encounter for administrative purposes

1.65

0.75

1.0

1.3

127.18

435.10

u/l

1.77

Hyperfunction of pituitary gland

1.60

0.75

1.2

157.75

402.48

u/l

0.88

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

2.09

0.74

1.2

1.0

65.40

688.05

u/l

—

Periodontitis

287

1759

1.09

0.74

1.1

1.3

353.20

310.38

u/l

0.31

265

1645

Other disorders of binocular movement

1.85

0.73

1.1

1.2

272.00

500.18

u/l

—

Cleft lip, lip and palate or palate

2.01

0.73

1.0

1.2

761.40

720.25

u/l

—

Problems related to social environment

1.80

0.72

1.0

1.1

117.29

625.03

u/l

—

Clear cell adenocarcinoma of kidney

1.58

0.71

1.1

1.2

504.83

414.77

u/l

0.08

Diabetic retinopathy, excluding more controls

338

1.19

0.71

1.2

112.38

221.82

u/l

4.99

318

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

202

1.33

0.71

1.2

223.37

323.55

u/l

0.53

185

Malignant neoplasm of oesophagus, including Hilmo

1.58

0.71

1.7

1.3

187.89

388.29

u/l

—

Provisional assignment of new diseases of uncertain etiology

145

1288

1.12

0.70

1.5

1.2

200.86

326.88

u/l

2.06

131

1189

Tuberculosis of other organs

1.93

0.70

1.0

140.80

676.35

u/l

—

Coxarthrosis, primary

161

1219

1.12

0.70

1.2

229.17

336.06

u/l

1.12

151

1133

Organic, including symptomatic, mental disorders

129

809

1.14

0.70

1.1

1.2

240.77

350.69

u/l

0.76

115

745

Unspecific neurodegenerative disorder

596

0.85

0.70

1.1

1.2

201.60

303.21

u/l

1.01

550

Respiratory tuberculosis, not confirmed

1.55

0.69

1.1

1.2

187.00

378.17

u/l

—

Chronic tubulo-interstitial nephritis

1.55

0.69

1.1

1.2

457.67

460.50

u/l

—

Codes for special purposes

145

1290

1.12

0.69

1.5

1.2

200.86

326.60

u/l

2.06

131

1191

Atopic dermatitis, strict definition

615

1.18

0.69

1.2

1.3

181.06

326.29

u/l

2.49

567

Certolizumab pegol

1.86

0.68

1.4

1.1

178.80

645.05

u/l

—

Anogenital herpesviral [herpes simplex] infection

110

1.46

0.68

1.1

1.3

188.00

368.68

u/l

0.99

Unspecified lump in breast

306

0.75

0.66

1.2

1.3

201.61

270.18

u/l

0.38

279

Injury of muscle and tendon at forearm level

1.79

0.66

1.2

1.1

248.60

666.30

u/l

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.79

0.66

1.2

1.1

184.20

585.22

u/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

117

706

1.14

0.66

1.2

180.81

335.44

u/l

2.17

107

653

Benign neoplasm: Cerebral meninges

162

1.36

0.66

1.2

160.47

268.23

u/l

0.75

148

Burn and corrosion confined to eye and adnexa

1.60

0.65

1.6

1.3

123.57

581.97

u/l

—

Benign neoplasm of urinary organs

1.57

0.65

1.1

1.2

148.45

416.86

u/l

1.10

Sequelae of cerebrovascular disease

682

1.15

0.64

1.2

200.43

413.80

u/l

2.19

627

Supervision of normal pregnancy

277

0.80

0.64

1.2

1.3

232.81

261.44

u/l

0.17

265

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

1.73

0.64

1.8

1.2

63.20

675.25

u/l

—

Gonarthrosis, primary, with knee surgery

156

1117

1.11

0.64

1.4

1.2

172.92

368.74

u/l

3.61

145

1042

Acute posthaemorrhagic anaemia

1.64

0.62

1.4

1.2

199.13

516.09

u/l

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

1.59

0.61

1.5

1.2

845.30

481.78

u/l

—

Tuberculosis of other organs, strict

1.67

0.61

1.0

140.80

570.38

u/l

—

Excessive attrition of teeth

154

1391

1.11

0.61

1.3

292.89

322.14

u/l

0.17

140

1294

Seropositive rheumatoid arthritis, wide

563

1.17

0.61

1.4

1.2

279.93

288.74

u/l

0.04

513

Progressive vascular leukoencephalopathy

1.57

0.60

1.0

1.1

88.50

369.18

u/l

—

Failed attempted abortion

0.00

0.59

0.0

1.1

—

940.94

—

Ankylosing spondylitis, strict definition

1.53

0.59

1.6

1.2

264.36

517.03

u/l

0.64

Other specified disorders of kidney and ureter

1.51

0.58

1.0

1.2

191.75

494.60

u/l

—

Type 1 diabetes, wide definition

427

1.19

0.58

1.2

138.09

405.08

u/l

4.11

391

Benign neoplasm: Colon, unspecified

520

1.17

0.57

1.1

1.2

185.18

343.03

u/l

1.30

478

Benign neoplasm: Larynx

1.48

0.57

1.4

1.3

145.25

459.04

u/l

—

Specific development disorders of speech and language

1.46

0.57

1.2

404.00

446.07

u/l

0.08

Amblyopia ex anopsia

1.51

0.56

1.0

1.2

116.27

428.17

u/l

1.31

Leiomyoma of uterus

168

866

1.10

0.55

1.3

1.2

246.51

260.70

u/l

0.08

158

811

Loose body in joint

1.63

0.55

1.0

1.4

160.33

649.56

u/l

—

Other noninflammatory disorders of cervix uteri

1.54

0.55

1.3

218.10

154.22

u/l

—

Contact with sharp object, undetermined intent

1.58

0.54

1.0

1.1

146.33

569.84

u/l

—

Other peripheral vascular diseases

142

1.34

0.54

1.1

1.2

707.47

300.95

u/l

0.48

130

Other or ill-defined heart diseases

1.47

0.54

1.3

310.92

508.68

u/l

0.61

Other benign neoplasm of uterus: Other parts/unspecified

1.48

0.53

2.0

1.1

266.89

320.58

u/l

—

Other and unspecified injuries of wrist and hand

1.48

0.53

1.0

1.1

223.22

288.90

u/l

—

Myeloid leukaemia

1.54

0.53

1.8

1.1

231.67

497.91

u/l

—

Traumatic amputation of wrist and hand

1.52

0.52

1.0

1.2

143.40

323.52

u/l

—

Granulomatous disorders of skin and subcutaneous tissue

1.50

0.51

2.0

1.1

141.17

523.44

u/l

—

Amputation of thigh

1.50

0.51

1.0

1.1

126.00

493.80

u/l

—

Degeneration of macula and posterior pole

118

845

1.11

0.51

1.3

1.2

285.58

330.29

u/l

0.18

104

784

Other disorders of cornea

170

1.30

0.51

1.4

1.3

118.27

398.45

u/l

2.72

155

Other/unspecified seropositive rheumatoid arthritis

555

1.15

0.51

1.2

286.62

289.78

u/l

0.01

506

Ptosis of eyelid

188

1.28

0.51

1.0

1.2

117.53

326.68

u/l

2.20

171

Malignant neoplasm of kidney, except renal pelvis

144

1.32

0.50

1.1

1.2

377.89

366.61

u/l

0.02

131

Systemic sclerosis (FG)

1.47

0.50

1.0

1.1

131.17

567.91

u/l

—

1.46

0.50

1.3

1.1

114.36

398.90

u/l

1.28

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

547

1.15

0.49

1.2

290.75

289.38

u/l

0.01

499

Hypertrophic cardiomyopathy

1.50

0.49

1.2

236.40

452.29

u/l

—

Abnormal findings on diagnostic imaging of central nervous system

1.50

0.49

1.3

253.50

435.51

u/l

—

Diabetic retinopathy

578

0.88

0.49

1.2

1.3

109.35

215.70

u/l

5.72

543

Other and unspecified diseases of blood and blood-forming organs

1.56

0.49

1.0

1.1

353.43

539.36

u/l

—

Other acquired deformities of musculoskeletal system and connective tissue

1.45

0.48

1.3

1.2

221.73

420.61

u/l

0.72

Malignant neoplasm of endocrine gland

119

1.35

0.48

1.0

1.2

173.00

334.96

u/l

0.95

106

Basal cell carcinoma

108

673

1.11

0.47

1.2

165.42

340.58

u/l

2.60

621

Isolated proteinuria

1.46

0.47

1.3

1.2

586.86

559.29

u/l

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

164

1.28

0.46

1.1

1.2

349.43

341.21

u/l

0.01

149

Contraceptive management

115

730

1.10

0.46

1.2

1.3

294.02

358.72

u/l

0.37

107

686

Brain meningioma, including Hilmo

0.61

0.45

1.2

105.60

374.84

u/l

—

Ulcer of lower limb, not elsewhere classified

264

1.21

0.45

1.3

1.2

233.27

330.89

u/l

0.48

243

Burns and corrosions confined to eye and internal organs

1.40

0.45

1.6

1.4

123.57

567.44

u/l

—

Benign neoplasm: Other and unspecified parts of mouth

1.40

0.45

1.3

1.1

206.43

503.47

u/l

—

Pregnancy with abortive outcome

172

828

1.08

0.45

1.2

186.38

263.66

u/l

1.20

151

779

Malignant neoplasm of thyroid gland

112

1.34

0.44

1.0

1.2

176.27

348.65

u/l

0.95

LeFortI or BSSO operation

1.45

0.44

1.1

1.3

141.40

437.33

u/l

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

1.37

0.44

1.0

1.2

154.43

468.53

u/l

—

Other benign neoplasms of skin

829

1.11

0.43

1.2

370.55

372.77

u/l

0.01

765

Optic neuritis

1.41

0.43

1.1

392.64

376.74

u/l

0.03

Hidradenitis suppurativa

1.43

0.42

1.3

256.63

482.92

u/l

—

Arterial embolism and thrombosis of lower extremity artery

1.43

0.42

1.0

1.1

184.81

401.06

u/l

—

Non-small cell lung cancer, squamous

1.43

0.42

1.0

1.3

185.38

208.88

u/l

—

Entropion and trichiasis of eyelid

122

1.31

0.42

1.3

1.2

108.63

391.81

u/l

2.05

112

Glaucoma-related operations

0.63

0.42

1.0

1.1

253.33

360.28

u/l

—

Burn and corrosion of wrist and hand

1.36

0.41

1.1

1.3

284.75

469.49

u/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

305

1.18

0.39

1.1

1.3

179.44

327.71

u/l

2.15

281

Congenital malformations of great arteries

1.45

0.39

1.0

1.2

219.00

588.29

u/l

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

1.43

0.39

1.2

1.1

131.80

648.97

u/l

—

Burns and corrosions of multiple and unspecified body regions

1.43

0.39

1.6

1.2

310.80

490.13

u/l

—

Vascular syndromes of brain in cerebrovascular disorders

1.41

0.39

1.1

1.2

141.20

389.17

u/l

—

Use of fingolimod

0.00

0.39

0.0

1.2

—

1050.79

—

Chronic nephritic syndrome

1.37

0.38

1.1

1.2

100.78

447.68

u/l

—

Pustulosis palmaris et plantaris

1.37

0.38

1.9

1.3

198.56

403.13

u/l

—

Glaucoma suspect

789

1.10

0.38

1.1

1.2

192.92

347.97

u/l

1.71

733

Polyuria

448

1.14

0.37

1.1

1.2

175.51

454.40

u/l

2.11

409

All dysplastic lesions of the cervix uteri, vagina or vulva

581

1.12

0.37

1.3

169.22

249.72

u/l

1.68

545

Seborrhoeic keratosis

468

1.13

0.36

1.2

159.51

314.18

u/l

2.80

434

Degenerative diseases of the nervous system

510

0.89

0.36

1.2

171.91

328.99

u/l

1.80

472

Basal cell carcinoma, including avohilmo

112

709

1.09

0.36

1.2

168.05

333.21

u/l

2.57

101

656

Melanoma in situ

0.66

0.35

1.0

1.2

223.00

389.90

u/l

—

Brain meningioma

0.64

0.35

1.2

105.60

382.17

u/l

—

Pedestrian injured in collision with pedal cycle

1.43

0.35

2.0

1.1

325.17

584.22

u/l

—

Cholesteatoma of middle ear

0.63

0.35

1.4

1.2

230.60

386.10

u/l

—

Follow-up examination after treatment for malignant neoplasms

190

0.79

0.35

1.4

1.2

189.73

272.61

u/l

0.73

174

Systemic sclerosis

1.40

0.35

1.0

1.1

131.17

510.59

u/l

—

Other obstetric trauma

1.34

0.34

1.2

338.36

253.55

u/l

0.26

Diabetic neuropathy

263

1.17

0.34

1.3

1.2

150.22

223.38

u/l

1.30

240

Undefined dementia

174

0.79

0.34

1.1

1.2

95.00

295.97

u/l

2.04

160

Benign neoplasm: other/unspecified salivary gland

1.34

0.33

1.2

1.1

154.83

495.47

u/l

—

Renal cell carcinoma of kidney

1.31

0.33

1.0

1.2

177.67

425.59

u/l

—

Postpartum haemorrhage

405

1.12

0.33

1.1

1.2

189.84

234.88

u/l

0.68

382

Pustular psoriasis

1.35

0.32

1.8

1.3

183.10

384.31

u/l

—

Benign lipomatous neoplasm

646

1.10

0.31

1.2

455.62

302.14

u/l

0.44

590

Other intracranial haemorrhages

1.35

0.31

1.0

1.3

213.43

584.32

u/l

—

Use of anticholinesterases

524

0.90

0.31

1.1

1.2

207.53

308.32

u/l

0.82

484

N06DA Anticholinesterases

524

0.90

0.31

1.2

207.53

308.32

u/l

0.82

484

Unspecified dementia

167

0.81

0.30

1.1

1.2

95.00

270.34

u/l

1.99

156

Covid-19 suspected case

463

0.89

0.30

1.1

1.2

208.14

305.50

u/l

0.86

427

Left ventricular outflow tract obstruction, narrow definition

1.33

0.30

1.1

1.4

159.10

401.88

u/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

333

1.14

0.30

1.1

1.3

176.85

333.08

u/l

2.35

307

Hereditary corneal dystrophies

1.27

0.30

1.3

1.1

118.71

465.94

u/l

—

Disorder of external ear, unspecified

1.27

0.30

1.4

1.3

167.29

512.98

u/l

—

Delivery

499

0.92

0.30

1.2

192.54

247.23

u/l

0.73

467

Hyperprolactinaemia

1.23

0.29

1.3

1.2

181.86

414.24

u/l

—

Autoimmune hyperthyroidism

110

0.73

0.28

1.3

1.2

218.00

337.89

u/l

—

100

Exposure to unspecified factor

283

1950

1.04

0.28

1.3

1.2

498.65

286.58

u/l

0.94

258

1830

Chronic suppurative otitis media, including avohilmo

130

1.23

0.28

3.5

1.3

168.75

332.10

u/l

0.97

117

Squamous cell neoplasms and carcinomas of the skin

121

1.24

0.28

1.3

1.2

272.73

300.94

u/l

0.07

112

Multiple delivery

151

0.79

0.28

1.0

1.2

236.08

287.45

u/l

0.19

137

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

119

755

1.07

0.27

1.2

174.98

326.30

u/l

2.31

109

698

Stenosis and insufficiency of lacrimal passages

149

1.21

0.27

1.3

1.2

109.22

329.46

u/l

1.85

134

Respiratory insufficiency

103

1.26

0.27

1.5

1.2

99.05

403.47

u/l

2.43

Other ill-defined and unspecified causes of mortality

117

0.77

0.27

1.0

1.2

123.83

417.08

u/l

—

108

Other and unspecified types of non-Hodgkin lymphoma, hilmo

1.23

0.27

1.3

1.2

174.50

403.30

u/l

—

Persons encountering health services in circumstances related to reproduction

137

979

0.94

0.27

1.2

1.3

282.26

332.16

u/l

0.36

125

913

Malignant melanoma

257

0.86

0.26

1.1

1.2

392.59

303.19

u/l

0.22

233

Caught, crushed, jammed or pinched in or between objects

1.28

0.26

1.8

1.4

702.18

488.21

u/l

0.16

Disorders of orbit

0.69

0.26

2.0

1.4

146.60

425.81

u/l

—

Other benign neoplasms of uterus

1.30

0.26

1.9

1.1

266.30

350.04

u/l

—

Male infertility

0.69

0.26

1.2

1.5

560.40

409.88

u/l

—

Maternal care for known or suspected disproportion

1.23

0.25

1.1

1.2

167.89

254.79

u/l

—

Hypermetropia

123

1.22

0.25

1.5

1.2

199.53

326.28

u/l

0.61

112

Malignant neoplasm of skin

123

794

1.06

0.24

1.2

225.06

346.83

u/l

1.20

113

737

Chronic iridocyclitis

0.74

0.24

1.0

1.2

384.17

401.67

u/l

—

Other hammer toe(s) (acquired)

288

1.12

0.23

1.3

1.2

226.83

320.66

u/l

0.73

264

Polypectomy (DHB20)

115

1.22

0.23

1.1

1.3

165.29

426.90

u/l

1.66

108

Other disorders of optic [2nd] nerve and visual pathways

1.24

0.23

1.2

183.92

370.07

u/l

0.80

Failed induction of labour

0.77

0.22

1.1

1.3

238.86

262.33

u/l

—

Coxarthrosis, primary, with hip surgery

115

1017

1.06

0.22

1.2

256.31

344.72

u/l

0.60

108

942

Single spontaneous delivery

498

0.94

0.22

1.2

199.35

247.13

u/l

0.60

466

Amputation of foot

1.22

0.22

1.0

1.3

77.00

477.92

u/l

—

Testicular dysfunction, other/unspecified

0.00

0.21

0.0

1.4

—

320.70

—

Malignant neoplasm of cervix uteri, including Hilmo

1.19

0.21

1.4

1.1

164.00

556.19

u/l

—

Viral agents as the cause of diseases classified to other chapters

1.19

0.21

1.2

485.60

507.67

u/l

—

Carcinoma in situ of prostate

0.00

0.21

0.0

1.1

—

208.00

—

Congenital malformations of heart and great arteries

222

1.14

0.21

1.0

1.3

184.38

383.76

u/l

2.24

203

Any dementia, excluding more controls

448

1.08

0.21

1.2

1.1

278.98

384.12

u/l

0.35

409

Benign neoplasm: Choroid

104

0.77

0.21

2.0

1.3

240.17

345.44

u/l

—

Benign neoplasm: Liver

1.16

0.21

1.4

1.2

184.20

517.81

u/l

—

Malignant neoplasm of thyroid gland, including Hilmo

126

1.19

0.21

1.0

1.2

176.27

327.36

u/l

0.90

112

Combinations of oral blood glucose lowering drugs

624

1.07

0.20

1.2

1.3

199.19

439.97

u/l

2.47

575

Disorders of plasma-protein metabolism, not elsewhere classified

0.00

0.20

0.0

1.1

—

283.71

—

Benign neoplasm: Conjunctiva

1.20

0.19

1.0

1.2

165.67

501.00

u/l

—

Systemic lupus erythematosus, unspecified

1.18

0.19

1.0

1.2

436.00

459.59

u/l

—

Dissection of aorta

1.18

0.19

1.2

1.1

108.67

378.70

u/l

—

Graves disease, strict definition

186

0.86

0.19

1.2

1.3

233.06

300.56

u/l

0.43

172

Sixth [abducent] nerve palsy

1.15

0.19

1.8

1.3

251.17

512.00

u/l

—

Systemic lupus erythematosus

1.13

0.18

1.0

1.2

436.00

429.23

u/l

—

Bilateral sagittal split ramus osteotomy operation

1.21

0.18

1.1

1.2

148.00

456.94

u/l

—

Dementia

625

0.95

0.17

1.1

1.2

260.44

357.84

u/l

0.42

578

Disorders of speech understanding and production

1.13

0.17

1.3

1.2

354.57

500.09

u/l

—

Systemic atrophies primarily affecting the central nervous system

0.76

0.17

1.2

122.74

438.90

u/l

—

Benign neoplasm of other and unspecified female genital organs

0.72

0.17

1.0

1.2

97.00

387.66

u/l

—

Other diseases of pericardium

1.16

0.16

1.1

1.3

226.00

580.29

u/l

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

109

1.17

0.16

1.8

1.2

653.92

396.61

u/l

0.21

Family history of certain disabilities and chronic diseases leading to disablement

0.80

0.14

1.0

1.2

88.00

394.10

u/l

—

Other mental disorders due to brain damage and dysfunction and to physical disease

208

1.11

0.14

1.1

1.2

180.56

282.66

u/l

0.91

194

Allergic conjunctivitis

144

1356

1.03

0.14

1.6

1.2

211.69

302.24

u/l

1.54

137

1265

Impacted maxillary molar

0.82

0.13

1.1

1.2

419.50

394.05

u/l

—

Benign neoplasm of major salivary glands

170

1.12

0.13

1.3

182.47

357.12

u/l

1.25

159

Postpartum hemorraghe, all women as controls

503

1.06

0.12

1.1

1.3

189.84

253.00

u/l

1.00

474

Injury of muscle and tendon at hip and thigh level

171

1.11

0.12

1.2

240.79

363.47

u/l

0.56

159

Malignant melanoma of skin

179

0.89

0.12

1.1

1.2

463.25

328.40

u/l

0.24

162

Delivery, wide proxy

395

0.95

0.12

1.1

1.2

332.36

230.45

u/l

0.29

370

Other disorders of veins

920

0.96

0.12

1.2

254.85

323.22

u/l

0.37

854

Dementia, including avohilmo

684

0.96

0.11

1.1

1.2

247.12

345.20

u/l

0.48

630

Cardiodefibrillation

817

1.04

0.10

1.2

247.35

387.27

u/l

1.26

757

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

139

1131

0.97

0.10

1.2

381.34

315.03

u/l

0.14

132

1056

Care involving use of rehabilitation procedures

171

1534

1.02

0.10

1.1

1.3

233.14

276.75

u/l

0.71

155

1435

All dysplastic lesions of the vagina

1.14

0.10

1.4

1.1

83.60

474.00

u/l

—

Sequelae of injuries of neck and trunk

1.14

0.10

1.4

1.3

95.60

565.64

u/l

—

Scissor bite

1.10

0.09

1.4

1.2

189.60

472.77

u/l

—

Other complications of labour and delivery, not elsewhere classified

186

1.09

0.09

1.1

1.3

212.00

238.34

u/l

0.17

171

Benign neoplasm: Liver/bile ducts

1.06

0.09

1.4

1.2

184.20

487.63

u/l

—

Erosion of teeth , including avohilmo

536

1.04

0.09

1.5

1.2

293.35

306.09

u/l

0.06

493

Laparoscopic right hemicolectomy

1.13

0.09

1.3

1.2

152.91

299.85

u/l

0.73

SLE, strict definition

1.09

0.09

1.0

1.2

436.00

443.26

u/l

—

SLE, ICD10

1.09

0.09

1.0

1.2

436.00

443.26

u/l

—

Bicuspidal aortic valve syndrome

1.03

0.08

1.0

1.4

180.33

464.94

u/l

—

Helminthiases

0.83

0.08

1.2

248.00

454.58

u/l

—

Complications of the puerperium, not elsewhere classified

0.82

0.08

1.0

1.2

320.40

246.22

u/l

—

Other surgical follow-up care

0.79

0.08

1.0

1.2

136.08

440.84

u/l

—

Giant cell arteritis

0.79

0.08

1.8

1.2

79.00

402.40

u/l

—

Other other unspecified disorders of the circulatory system

0.77

0.08

1.2

217.60

441.70

u/l

—

Malignant neoplasm of mesothelium and soft tissue

1.09

0.08

1.7

1.3

308.86

465.86

u/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

154

0.91

0.08

1.4

1.3

185.86

330.63

u/l

0.83

145

Primary open-angle glaucoma, strict

530

0.96

0.08

1.1

1.2

321.68

321.76

u/l

0.00

492

Viral conjunctivitis

1.08

0.08

1.3

140.57

432.28

u/l

—

Sequelae of infectious and parasitic diseases

123

0.89

0.08

1.1

1.3

734.82

344.96

u/l

0.28

111

Fracture of forearm

138

1236

1.02

0.08

1.2

220.39

356.58

u/l

1.42

131

1141

Other abnormal findings of blood chemistry

1.05

0.07

1.4

1.2

152.00

417.18

u/l

—

Skin changes due to chronic exposure to nonionizing radiation

762

1.03

0.07

1.1

1.2

194.74

331.92

u/l

1.09

700

L02BX Other hormone antagonists and related agents

0.82

0.07

1.1

1.2

339.00

353.10

u/l

—

Postpartum hemorraghe, parous women as controls

443

1.04

0.07

1.1

1.3

189.84

262.84

u/l

1.14

417

Papillary adenocarcinoma of thyroid gland

1.12

0.07

1.0

1.3

189.20

378.63

u/l

—

Sequelae of other and unspecified infectious and parasitic diseases

0.88

0.06

1.1

1.3

972.37

393.40

u/l

—

Malignant neoplasm of stomach, including Hilmo

0.88

0.06

2.1

1.2

529.88

370.91

u/l

—

L01XE Protein kinase inhibitors

0.85

0.06

1.6

1.2

1030.75

407.28

u/l

—

L01XX Other antineoplastic agents

1.11

0.05

1.9

1.2

294.20

398.87

u/l

—

Chalazion

198

1.06

0.05

1.0

1.3

1248.95

368.86

u/l

0.37

180

Other disorders of penis

159

1.07

0.05

1.1

1.3

129.65

409.75

u/l

3.20

148

Primary open-angle glaucoma

634

0.98

0.04

1.1

1.2

281.93

300.20

u/l

0.05

581

Pregnancy, childbirth and the puerperium

332

0.98

0.04

1.2

320.19

224.94

u/l

0.23

310

Other sexually transmitted chlamydial diseases

109

0.92

0.04

1.1

1.3

362.30

411.13

u/l

—

Glaucoma

135

1146

1.01

0.04

1.1

1.2

240.03

318.90

u/l

0.57

118

1069

Chronic suppurative otitis media

111

1.08

0.04

4.3

1.3

181.08

350.05

u/l

0.78

100

Paralytic strabismus

121

1.07

0.03

1.4

1.2

163.15

360.04

u/l

1.27

112

Malignant neoplasm of bladder

1.09

0.03

1.2

203.90

335.15

u/l

—

Congenital malformations of eye, ear, face and neck

108

0.93

0.03

1.4

1.3

163.50

396.14

u/l

—

Any dementia

550

0.98

0.02

1.2

258.10

301.41

u/l

0.17

505

Thyrotoxicosis with toxic multinodular goitre

1.08

0.02

1.0

1.2

159.80

341.81

u/l

—

Benign neoplasm: Parotid gland

137

0.95

0.01

1.3

195.23

343.12

u/l

0.76

130

818

1.01

0.01

1.1

1.2

190.26

340.31

u/l

1.36

755

Actinic keratosis

744

1.01

0.00

1.1

1.2

198.05

327.71

u/l

0.96

683

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

131

1268

1.00

0.00

1.6

1.2

216.14

307.94

u/l

1.40

124

1182

Spontaneous abortion

101

678

1.00

0.00

1.3

1.2

218.37

261.99

u/l

0.36

640

Benign neoplasm of eye and adnexa

176

1.02

0.00

1.5

1.2

199.63

338.64

u/l

0.94

164

Melanocytic naevi

635

1.01

0.00

1.1

1.2

222.23

296.96

u/l

0.91

587

Memory loss

159

1.01

0.00

1.3

1.2

168.50

306.97

u/l

1.01

146

Fitting and adjustment of external prosthetic device

0.00

0.0

1.4

—

124.00

—

Non-seminoma of testis, including Hilmo

0.00

0.0

1.4

—

391.00

—

Other secondary gout

0.00

0.0

1.0

—

137.86

—

Crushing injury of forearm

0.00

0.0

1.3

—

101.33

—

Acute disseminated encephalitis/encephalomyelitis

0.00

0.0

1.4

—

137.00

—

Other specified and unspecified disorders of choroid

0.00

0.0

1.3

—

1307.38

—

Feeding problems of newborn

0.00

0.0

1.7

—

132.83

—

Maternal care for cervical incompetence

0.98

-0.00

1.0

1.1

244.50

419.24

u/l

—

SLE (Finngen)

1.02

-0.00

1.0

1.2

436.00

450.96

u/l

—

Vertical strabismus

0.89

-0.00

1.0

1.2

90.80

455.90

u/l

—

Peripheral retinal degeneration

1.00

-0.00

1.4

1.1

344.40

497.51

u/l

—

Posteruptive colour changes of dental hard tissues

0.00

-0.00

0.0

1.2

—

140.20

—

Other acantholytic disorders

0.00

-0.00

0.0

1.0

—

120.83

—

Transient acantholytic dermatosis [Grover]

0.00

-0.00

0.0

1.0

—

125.40

—

Fatigue fracture of vertebra

0.00

-0.00

0.0

1.0

—

185.20

—

Other specified/unspecified diseases of inner ear

0.00

-0.00

0.0

1.3

—

118.50

—

Failure of sterile precautions during surgical operation

0.00

-0.00

0.0

1.0

—

130.43

—

Adult-onset Still disease

0.00

-0.00

0.0

1.2

—

299.89

—

Cerebral oedema

0.00

-0.00

0.0

1.3

—

120.67

—

Disorders of hypoglossal nerve

0.00

-0.00

0.0

1.0

—

2023.00

—

Disorders of olfactory nerve

0.00

-0.00

0.0

1.0

—

2304.00

—

Other fibroblastic disorders

0.00

-0.00

0.0

1.3

—

183.14

—

Mononeuritis multiplex

0.00

-0.00

0.0

1.0

—

1694.50

—

Urethral discharge

0.00

-0.00

0.0

1.4

—

442.80

—

Nondiabetic hypoglycaemic coma

0.00

-0.00

0.0

1.4

—

132.20

—

Abuse of non-dependence-producing substances

0.00

-0.00

0.0

1.4

—

419.40

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

-0.00

0.0

1.8

—

134.60

—

Marasmic kwashiorkor

0.00

-0.00

0.0

1.4

—

187.60

—

Benign neoplasm: Scrotum

0.00

-0.00

0.0

1.2

—

127.56

—

Congenital malformations of aortic and mitral valves

1.00

-0.00

1.0

1.4

164.57

426.48

u/l

—

Organ-limited amyloidosis

0.00

-0.00

0.0

1.0

—

189.43

—

Benign neoplasm: Skin of ear and external auricular canal

0.94

-0.00

1.2

1234.00

432.95

u/l

—

Carcinoma in situ of skin of lip

0.00

-0.00

0.0

1.0

—

254.60

—

Felty syndrome

0.00

-0.00

0.0

1.3

—

110.13

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.00

-0.00

0.0

1.4

—

451.40

—

Benign neoplasm: Testis

0.00

-0.00

0.0

1.3

—

362.13

—

Benign neoplasm: Epididymis

0.00

-0.00

0.0

1.4

—

138.20

—

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

0.00

-0.00

0.0

1.0

—

391.00

—

Malignant neoplasm of stomach

0.93

-0.00

2.3

1.2

589.14

384.78

u/l

—

Hypersensitivity angiitis

0.00

-0.00

0.0

1.0

—

108.00

—

Pityriasis lichenoides et varioliformis acuta

0.00

-0.00

0.0

1.0

—

2019.20

—

Other effects of reduced temperature

0.00

-0.00

0.0

1.4

—

114.40

—

Degenerative conditions of globe

0.00

-0.00

0.0

1.0

—

102.40

—

Traumatic cerebral oedema

0.00

-0.00

0.0

1.0

—

497.67

—

Metabolic disorder, other/unspecified

0.00

-0.00

0.0

1.3

—

405.56

—

Traumatic amputation of ankle and foot

0.00

-0.00

0.0

1.3

—

335.71

—

Malignant neoplasm of gum

0.00

-0.00

0.0

1.4

—

181.20

—

Accident to watercraft causing drowning and submersion

0.00

-0.00

0.0

1.0

—

449.00

—

Discharge from other and unspecified firearms

0.00

-0.00

0.0

1.5

—

171.00

—

Abrasion of teeth

760

1.00

-0.00

1.1

1.3

464.90

284.32

u/l

0.54

700

Explosion of other materials

0.00

-0.00

0.0

1.3

—

392.50

—

Defect, injury or illness of face

0.00

-0.00

0.0

1.0

—

421.40

—

Listeriosis

0.00

-0.00

0.0

1.0

—

136.60

—

Congenital retinoschisis

0.00

-0.00

0.0

1.4

—

410.80

—

0.00

-0.00

0.0

1.4

—

2301.40

—

Congenital retinoschisis

0.00

-0.00

0.0

1.4

—

410.80

—

Polyglandular dysfunction

0.00

-0.00

0.0

1.0

—

141.20

—

Toxic erythema

0.00

-0.00

0.0

1.4

—

1976.60

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Amylase [Enzymatic activity/volume] in Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS